Abstract
Environmental enrichment (EE) is an environmental paradigm encompassing sensory, cognitive, and physical stimulation at a heightened level. Previous studies have reported the beneficial effects of EE in the brain, particularly in the hippocampus. EE improves cognitive function as well as ameliorates depressive and anxiety-like behaviors, making it a potentially effective neuroprotective strategy against neurodegenerative diseases such as Alzheimer’s disease (AD). Here, we summarize the current evidence for EE as a neuroprotective strategy as well as the potential molecular pathways that can explain the effects of EE from a biochemical perspective using animal models. The effectiveness of EE in enhancing brain activity against neurodegeneration is explored with a view to differences present in early and late life EE exposure, with its potential application in human being discussed. We discuss EE as one of the non pharmacological approaches in preventing or delaying the onset of AD for future research.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
With the increase in life expectancy due to advances in technology, the elderly population is projected to double to 1.5 billion in the year 2050 [1]. As such, the issue of neurodegenerative diseases and dementia is a ticking time bomb which could implode as time progresses. Alzheimer’s disease (AD) is the most common cause of dementia amongst this slew of neurodegenerative diseases. It was previously acknowledged as the top ten causes of death in the USA [2], and its mortality and morbidity rate in the elderly has only risen substantially since then [3]. Neurodegeneration in AD is caused by the abnormal processing and polymerization of normally soluble proteins [4]. The general consensus regarding the pathogenesis of AD involves the progressive extracellular aggregation of amyloid-beta (Aβ) plaques as well as intracellular aggregation of neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau proteins in the cortex and hippocampus [5]. More specifically, amyloid pathogenesis initially begins with dysfunctional cleavage of the amyloid precursor protein (APP), producing insoluble Aβ fibrils. Consequently, these Aβ fibrils then polymerise into insoluble amyloid fibrils that eventually aggregates into plaques. This polymerisation further causes the activation of kinases, resulting in hyperphosphorylation of tau proteins, and the eventual aggregation of insoluble NFTs. The progressive deposition of Aβ plaques and NFTs is followed by microglia recruitment surrounding the plaques, promoting the activation of microglia and local inflammatory response, leading to neurotoxicity [4]. Age, although not a direct cause, is the main risk factor associated with AD. The prevalence of AD increases significantly with age. An estimated 3% of adults aged 65–74, 17% of adults aged 75–84 and 32% adults aged 85 or older suffer from the disease [6]. Other potential risk factors such as chronic stress, genetic mutations and poor social relationships may also contribute to the pathogenesis of AD by facilitating Aβ deposition in the hippocampus [7, 8].
AD is a progressive disease where early symptoms of memory deterioration later develop into imparied social behavior and motor movements in patients. Patients suffering from AD typically progress slowly through four stages: the preclinical, early, middle, and late stages, each with varying clinical symptoms. During the pre-clinical stage, the individual experiences mild memory loss and early structural changes to the hippocampus, with no functional impairment of their daily activities [9]. Patients in the early stages experience progressive loss of concentration and memory and start to display depressive-like behaviors [10]. Should the disease progress to the moderate stage, this results in worsened memory and concentration, with difficulty in performing daily actions. Finally, patients suffering from late-stage AD will lose the ability to recognize individuals while also gradually losing control of their motor functions [5]. Currently, there are no known methods to prevent progression of Alzheimer’s, with the only clinical treatment available being drugs to alleviate the symptoms [11]. However, patients taking these drugs may experience side effects, such as gastrointestinal, fatigue, and potential abnormalities in breathing [12]. Hence, there is a need to develop a non-pharmacological presroach to prevent or delay the onset of AD.
The environmental enrichment paradigm was first explored by Donald Hebb, who demonstrated that socially enriched rats performed better in problem solving tests compared to their counterparts in standard housing [13]. Following this, Rosenzweig further established the concept of EE, whereby he classified EE as the combination of social stimulation along with the presence of various inanimate objects [14]. In the modern laboratory setting, EE is defined as the improvement of animal care quality in captive animals via the provision of appropriate stimuli needed to enhance physiological and psychological well-being [15]. For lab rodents, an enriched environment typically consists of larger cages and the presence of interactable objects as well as the rodents being housed together to stimulate social interactions [16]. Previously, studies have found that housing lab animals in EE had beneficial effects on their brain structure and behaviors. The main findings regarding the effects of EE on the brain can be summarized as improved spatial learning and memory consolidation [17, 18, 19], reduction of behaviors associated with depression and anxiety [20, 21, 22, 23], and reduction in age-related memory impairment [24, 25]. Initial studies investigating the effects of EE in preclinical models of neurodegenerative diseases were conducted in the early 2000s, particularly in Huntington’s disease and AD. In this regard, van Dellen et al., Hockly et al., and Spires et al. were some of the first to investigate the effects of EE on Huntington’s disease [26, 27, 28]. This led to several studies investigating the effects of EE on preclinical AD models, with varying degrees of success [29, 30]. Regardless, these initial studies were essential as they laid the foundation for EE as a potential therapy to combat neurodegenerative diseases. Throughout the past decade, many reviews have highlighted the effectiveness of EE against AD pathogenesis [31, 32, 33, 34, 35, 36]. Most notably, it has been shown that EE reversed Aβ pathology as well as reduced senile plaque aggregation in transgenic AD mice [37, 38]. Despite this, there is a lack of understanding regarding the molecular mechanisms associated with these changes in the brain. As such, this review serves not only to give an update to pre-existing literature but also to compile potential molecular pathways associated with EE and how it could influence the pathogenesis of AD as well as improve structures of the brain affected by it.
Environmental Enrichment as a Neuroprotective Strategy in the Hippocampus
Studies regarding AD have mainly focused on the entorhinal cortex (EC) and hippocampus due to the disease’s effect on memory formation, spatial navigation, and motor behavior [39]. Furthermore, the neuronal dysfunction of the EC-hippocampal network has also been previously implicated during the early stages of AD [40].
Traditionally, morphological and structural changes in the hippocampus, such as progressive loss of hippocampal volume, were observed in patients suffering from AD [41, 42]. The reduction of neurogenesis throughout the progressive stages has also been recorded [43, 44]. In this regard, several animal studies have previously highlighted the beneficial impacts of EE on hippocampal structures. It has been reported that hippocampal neurogenesis was promoted following exposure to EE [45]. EE primarily caused an increase in the proliferation of progenitor cells whilst also promoting cell survival in the hippocampus [46, 47, 48]. Similarly, this could also be observed in transgenic rodent models of AD, as EE restored impaired adult hippocampal neurogenesis after deposition of Aβ plaques [49, 50, 51]. The extent of neurogenesis varies between these studies, presumably due to differences in parameters such as the age of the rodents, duration of EE exposure, and differences in EE protocols used.
Additionally, both CA1 and dentate gyrus (DG) volumes in the hippocampus were also significantly increased after long-term exposure to EE, resulting in improved cognitive performance [52]. The increase in hippocampal volume could be attributed to the cumulative effects of EE, such as increased cell proliferation and dendritic arborization, as well as enhanced vascularity and dendritic complexity [53]. The effects of EE on hippocampal activity have also been of interest in recent years. Hippocampal activity is directly tied to the long-term potentiation (LTP) generated between hippocampal excitatory neurons, which are involved in the process of learning and the formation of memory [54]. In addition, synaptic dysfunction of the hippocampus is also implicated during the early stages of AD, leading to the progressive impairment of memories [55]. In recent AD studies using different transgenic rodent models, electrophysiological recordings of hippocampal LTP showed a marked decline in magnitude, suggesting reduced synaptic plasticity of the hippocampus [56, 57, 58]. Synapse loss and dysfunction had also been heavily correlated with cognitive decline associated with AD subjects [59, 60].
The effects of EE on synaptic plasticity in the hippocampus have been frequently discussed in multiple rodent models. Hippocampal LTP was found to be enhanced following exposure to short-term EE [61, 62]. Whole-brain deep sequencing analysis post-EE exposure revealed upregulation of genes associated with synaptic plasticity, such as brain-derived neurotrophic factor (BDNF) and the N-methyl D-Aspartate receptor subtype 2B (GRIN2B) genes [52]. In seizure-prone models of rodents, EE preserved hippocampal LTP in CA1 neurons, while preventing loss of synaptic density and dendrite branching [63]. A recent study also investigated the effects of EE on hippocampal plasticity in permanent middle cerebral artery occlusion models of mice. After 28 days of exposure to EE, protein expression for synaptic proteins (such as growth-associated protein 43 (GAP-43), synaptophysin, and postsynaptic density protein 95 (PSD-95)) were found to be significantly increased compared to the mice housed in standard housing conditions, leading to the formation of higher amounts of hippocampal synapses [64]. Moreover, these effects could also be observed in transgenic AD rodents. A prime example can be found in the use of EE to enhance synaptic plasticity in transgenic AD mice expressing mutations in the amyloid precursor proteins (APP) and presenilin 1 (PS1) genes (APPswe/PS1ΔE9). Furthermore, 4 weeks of EE prevented synaptic impairment induced by Aβ Oligomer deposition [65], indicating the potential of EE as both a neuroprotection and treatment strategy. A summary of the effects of EE on the hippocampus is tabulated in Tables 1 and 2.
Besides influencing the structure and neuronal activity of the hippocampus, EE also functions as a neuroprotective and treatment strategy by preventing and/or reducing the accumulation of Aβ plaques during the progressive stages of AD. Early exposure to EE can attenuate amyloid pathology as evidenced by decreased Aβ deposition in the cortex and hippocampus of transgenic mice with overproduction of Aβ peptides and accelerated amyloid deposition (FAD-linked APPswe/PS1ΔE9) [37]. Additional studies also reported significantly reduced Aβ levels in the hippocampus and cortex post-EE exposure, before the onset of amyloid deposition [66, 67]. In tandem, tau phosphorylation was also significantly decreased, resulting in reduced formation of NFT and neurophil threads [68]. The preventive effects of EE on amyloid deposition could be attributed to increased amyloid clearance, as EE induced expression of Aβ degrading molecules, altered Aβ transporters levels as well as activated microglial clearance [69, 70]. Interestingly, an earlier study highlighted an increase in Aβ deposition and levels resulting from early exposure to EE [71, 72]. Furthermore, some studies have even recorded no changes in Aβ deposition, though they noted an improvement in cognitive functions [73, 74]. Presumably, the differences in results could be due to variances in parameters, such as the model of transgenic rodents used, housing conditions for EE, and sex of rodents.
Although the neuroprotective property of EE is apparent during early intervention, its effectiveness in mid-life and aged models of AD has only recently gained attention. EE exposure during mid and late-life phases has yielded conflicting results in recent studies. Initially, a study conducted by Stuart et al. only observed an increase in CA1 synaptic density after long-term EE exposure to 6 months old mice, with no noticeable changes to Aβ plaque load in the hippocampus and neocortex [75]. Additionally, long-term stimulation of EE did not affect Aβ oligomer levels but was found to have a profound effect on hippocampal senile plaque concentration in mid-life mice (8–12 months) [38]. In contrast, Fulopova et al. described regional changes in amyloid deposition, with Aβ plaque formation in the somatosensory and primary motor cortex being significantly reduced while observing no changes in the prefrontal cortex of mid-life APP/PS1 mice [76]. Similarly, in aged APPsw transgenic mice (20–22 months), 4 months of EE exposure did not alter Aβ deposition but instead improved cognition in these mice [74]. On the other hand, Mainardi et al. observed a decrease in hippocampal Aβ oligomer levels in 17-month-old mice, attributing this to the increased synthesis of the Aβ-degrading enzyme neprilysin caused by EE [77]. Although the efficacy of EE during the early stages has been well documented, these findings suggest that more studies need to be conducted to determine its effectiveness during mid-late life.
Potential Molecular Mechanisms Associated with EE in the brain
Despite existing evidence supporting the effectiveness of EE as a non-pharmacological approach in delaying the onset of AD, the underlying mechanisms behind how it achieves this has yet to be well understood. EE stimulates growth and proliferation pathways which delay the progression of AD. As such, this subtopic will discuss the molecular mechanisms associated with counteracting the effects of AD.
A major point of interest in EE is in its effect on hippocampal neurogenesis. As previously mentioned, EE serves as a neuroprotective strategy by promoting neurogenesis, as indicated by increased cell proliferation and cell survival in the hippocampus [46, 47, 48]. A plethora of studies indicate that EE promotes the expression of neurotrophins, such as brain-derived neurotrophic factor (BDNF) [78, 79, 80, 81]. and nerve growth factors (NGF) in the hippocampus [82, 83]. BDNF is a neurotrophin that induces the differentiation and survival of neurons [84]. BDNF also activates downstream pathways associated with regulating excitatory and inhibitory synaptic transmission in the adult brain. These actions are primarily exerted via BDNF activation of multiple downstream pathways upon binding with its receptor, tyrosine receptor kinase B (TrkB) [85].
Phosphoinositide-3 Kinase/Protein Kinase B Pathway
The initial increase in BDNF levels induced by EE could be due to upregulated expression of tissue plasminogen activator (tPA), which converts plasminogen into plasmin and consequently increases conversion of proBDNF (inactive) into mature BDNF [86, 87]. The mature form of BDNF then preferentially binds to TrkB instead of neurotrophin receptor p75 (p75NTR). Concomitantly, the expression of TrkB receptors is also increased in response to EE [22, 87, 88]. The binding of mature BDNF to TrkB subsequently causes activation of multiple pathways (Fig. 1). One of them is through the activation of the phosphoinositide-3 kinase/protein kinase B (PI3k-Akt) pathway as evidenced by the increased phosphorylation of Akt after different periods of EE exposure [46, 87, 89].
Nuclear Factor-Kappa B Pathway
Although the nuclear factor-kappa B (NF-κB) pathway has previously been extensively involved in the development and progression of cancer, recent reviews have highlighted the potential of the NF-κB pathway as a therapeutic target for AD [90, 91]. The NF-κB belongs to a family of transcription factors typically associated with the regulation of inflammation. In AD, the NF-κB is essential for the modulation of beta-secretase 1 encoded by the BACE1 gene. BACE1 initiates the production of Aβ with gamma-secretase, which cleaves a portion of the amyloid precursor proteins (APP), resulting in the accumulation of Aβ plaques between hippocampal neurons [92]. Overactivation of the NF-κB pathway leads to increased promoter activity of APP and BACE1 genes, resulting in elevated Aβ accumulation [93, 94]. Moreover, NF-κB codes for various target genes relevant to the formation of long-term memory and hippocampal plasticity [95], indicating that dysregulation of this pathway could lead to impairments in hippocampal function. P-Akt regulates the transcriptional activity of NFκB by inducing the phosphorylation and consequent degradation of inhibitor of κB (IkK), thereby activating it [96].
Studies regarding the NF-κB pathway yielded conflicting results. For example, EE-dependent activation of NFκB promoted the expression of hippocampal genes essential for learning plasticity and learning (e.g., BDNF and CamK2D) in old age rats, resulting in improved adult neurogenesis and healthier synaptic densities [97]. In addition, early-life EE exposure in an accelerated aging model of mice (SAMP8 mice) causes downregulation of inflammatory genes associated with NFκB (IL-6, Cxcl10) while also upregulating antioxidant genes (Hmox1, Aox1, Cox2) [98]. In contrast, exposure of mid-life 5xFAD mice (mice expressing human APP and PSEN1 transgenes with five AD-linked mutations) to 3 months of EE caused an upregulation of microRNA-146a, resulting in down-regulation of NF-κB and inhibition of astrocytic inflammation [99]. Reduced expression of NF-κB was also seen in EE-exposed diabetic streptozotocin rats, consequently leading to decreased hippocampal neuronal loss and astroglial inflammation whilst also increasing synaptic density [100]. Additionally, EE also influences the expression of the BACE1 gene. Though not in AD models, EE reduced BACE1 expression in both young and aged mice following chronic variable stress [101]. As such, the NF-κB is a challenging pathway to focus on since it regulates the transcription of both Aβ related genes and genes related to hippocampal function. Although EE regulates this pathway bidirectionally, its corresponding effects are different. On one hand, upregulation of NF-κB is essential for preserving and improving hippocampal structure. On the other hand, increasing NF-κB signaling could also lead to increased BACE1 expression, leading to increased Aβ deposition [93]. Inversely, downregulation of NF-κB could lead to a reduction in BACE1 expression [102]; however, it could also have profound effects on other genes involved in cell survival, cell proliferation, and cell differentiation. The NF-κB pathway is activated during aging and contributes to the pathogenesis of age-related diseases. Hence, EE could potentially aid in the modulation of this pathway by preventing over-activation during the aging process.
Glycogen Synthase Kinase 3 Beta Pathway
Another pathway that could potentially be influenced by EE is the glycogen synthase kinase 3 beta (GSK-3β) pathway. Dysregulation of GSK-3β is indeed associated with increased deposition of Aβ plaques in the hippocampus. Furthermore, the overactivation of GSK-3β promotes hyperphosphorylation of toxic tau protein and consequently the formation of NFT [103]. GSK-3β overexpression also causes morphological alterations in hippocampal granule neurons like that of AD patients [51]. In contrast, inhibition of GSK-3β has been shown to attenuate cell death associated with the early introduction of neurotoxic Aβ peptides, and ameliorate behavioral changes induced by AD [104, 105]. The phosphorylated state of Akt (p-Akt) inhibits GSK-3β activity by phosphorylation at the Ser9 site [106], potentially causing reduced tau hyperphosphorylation and reversing synaptic abnormalities through inhibition of BACE1 [51, 107]. Indeed, this may be one of the pathways associated with the decreased levels of Aβ after exposure to EE [77]. Furthermore, inhibition of GSK-3β can enhance adult neurogenesis. Previous studies have demonstrated that the inhibition of this kinase led to increased neural stem cell proliferation as well as increased neuronal differentiation in both in vivo and in vitro models [108, 109]. Similarly, EE restored proliferation of neural precursor cells in GSK-3β knock-in mice [110] However, its effects were only noticeable in males, but not in their female counterparts.
Overactivation of GSK-3β was also rescued by EE exposure. Specifically, EE reversed morphological alterations induced by GSK-3β overactivation in adult neurons, resulting in improved synaptic plasticity [51]. However, the upstream signaling cascades involved in this particular process remain poorly understood. Realistically, a combination of different pathways could lead to such attenuation as both the PI3k-Akt and NF-κB signaling cascades are involved in regulating GSK-3β activity [107, 111].
Cyclic-AMP Response Element-Binding Pathway and Forkhead Box O3 Transcription Factor
The activation of the PI3k-Akt pathway also promotes adult neurogenesis via the involvement of different downstream signaling cascades. These pathways have mainly been associated with cell proliferation, cell survival, and cell differentiation. In addition to the NFκB and GSK-3β pathways, the cyclic-AMP response element-binding (CREB) protein has been shown to play an essential role in hippocampal function as it mediates the expression of genes involved in cell proliferation and survival [112, 113]. Activation of CREB via phosphorylation of PI3k-Akt has previously been shown to trigger the proliferation of adult hippocampal progenitor cells [114]. Furthermore, activation of CREB led to enhanced hippocampal synaptic plasticity as well as heightened neuronal excitability [115, 116, 117]. The majority of the studies conducted have indicated that EE increased expression and/or phosphorylation of CREB in some capacity [87, 116, 118]. However, one study failed to replicate this effect [119]. This could be due to a lack of physical enrichment, as the later study lacked the novelties needed to stimulate physical activity. Indeed, physical activity has been shown to elicit activation of CREB in the hippocampus [120, 121]. Besides that, PI3k-Akt can enhance cell survival via the involvement of the Forkhead box O3 transcription factor (FOXO3a). FOXO3a is primarily involved in the process of apoptosis via upregulation of genes essential for cell death, such as Bim and p53 [122]. Phosphorylation of FOXO3a by Akt causes its localization in the cytosol as an inactive complex bound [123]. Inactivation of FOXO3a prevents apoptosis of cells, leading to increased cell survival.
Mitogen-Activated Protein Kinases/Extracellular Signal-Regulated Kinase Pathway and Other Potential Factors
Alternatively, binding of BDNF to TrkB could also activate the Mitogen-activated protein kinases/extracellular signal-regulated kinase (MAPK/ERK) pathway, which is essential in cell proliferation, differentiation, migration, and apoptosis [124]. Similar to the PI3k/Akt pathway, MAPK/ERK promotes cell proliferation through activation of CREB [125]. Activation of CREB through the MAPK/ERK pathway is mediated by pp90 ribosomal S6 kinase (RSK), mitogen- and stress-activated protein kinase (MSK)1/2. MAPK/ERK could also influence cell proliferation via other downstream transcription factors, such as ELK-1 and c-Myc [126, 127]. Previous studies have reported how EE influences the MAPK/ERK pathway. Bengoetxea et al. reported that animals reared in EE reversed neuronal and vascular deficiencies induced by the effects of vandetanib, a Trk inhibitor [89]. The group attributed this recovery to the activation of PI3k-Akt and MAPK pathways caused by EE-mediated BDNF-TrkB binding. Furthermore, another group noted that MSK1 is an essential component for EE-induced effects. More specifically, they noted that EE had diminished spinogenesis and SGZ progenitor proliferation in MSK1 knockout mice compared to their wild-type counterparts [128]. In contrast, other studies have recorded no changes in hippocampal ERK levels after exposure to EE [87, 129].
Wingless-Type MMTV Integration Site Family/β-Catenin Signaling Pathway
Interestingly, one of the least discussed pathways regarding AD is the wingless-type MMTV integration site family (Wnt)/β-catenin pathway. This pathway was first recognized for its involvement in carcinogenesis [130]. However, a growing amount of evidence has supported its involvement in the pathology of AD [131, 132]. The Wnt/β-catenin pathway is responsible for a number of essential biological processes, such as cell survival and cell proliferation, as well as synaptic plasticity [133]. Inhibition of the Wnt signaling cascade is often studied to prevent proliferation and migration in cancer cells [134, 135, 136]. Moreover, inhibition of the Wnt causes synthesis of Aβ oligomers and aggregation of Aβ plaques [137, 138]. Restoration of this dysregulated pathway could ameliorate symptoms and delay the progress of AD. Although limited, recent studies have focused on how EE affects the Wnt signaling cascade. Surprisingly, EE induced activation of Wnt/β-Catenin in rodents with vascular dementia, effectively restoring spatial learning and memory [17]. Moreover, exposure of middle-aged and aged rats to exercise and enrichment induced hippocampal activation of the canonical Wnt pathway [139, 140], potentially improving hippocampal plasticity and neuronal densities. Although these are promising effects, more studies are needed to determine how EE with and/or without the presence of exercise could affect the Wnt signaling cascade.
Nerve Growth Factor (NGF), pro-NGF, and the c-Jun N-terminal Kinase (JNK) Signaling Pathways
Although EE primarily produces their neuroprotective effects through BDNF, the signaling pathways induced by other neurotrophins should also be considered. Another promising area of interest is the basal forebrain due to its involvement in AD. The basal forebrain provides a major source of cholinergic innvervations to the hippocampus and cortical areas [141]. The loss of these cholinergic neurons could impair hippocampal processing information and potentially contribute to AD-related psychiatric symptoms [142]. Furthermore, a recent study also demonstrated that the neurodegeneration of basal forebrain precedes even that of the entorhinal cortex during the pathogenesis of AD [143]. Nerve growth factor (NGF) is essential for the functioning of the basal forebrain as it contributes to the formation of dendritic trees and modulates the activity of cholinergic systems projecting to the hippocampus [144]. During the pre-clinical and early stages of AD, NGF metabolism is dysregulated [145], leading to higher amounts of proNGF (precursor) which results in loss of cortical synapses and atrophy of cholinergic neurons in the basal forebrain. As such, current-day studies have focused on the biodelivery of NGF to degenerated cell bodies in the basal forebrain as a treatment method [146, 147, 148], in an attempt to resuscitate cholinergic signaling in the cortex and hippocampus [149].
The effects of EE on NGF are similar to its effects on BDNF expression, where multiple studies have noted an increase in NGF in response to both short and long-term exposure of EE [82, 150, 151, 152, 153]. Presumably, this increase in NGF levels could be attributed to the upregulation of plasmin, as plasmin functions to convert proNGF to mature NGF (mNGF). NGF’s mechanism of action is also similar to that of BDNF. However, one key difference is that NGF initially binds to tyrosine kinase A instead of tyrosine kinase B. This leads to the activation of the PI3k-Akt and MAPK-ERK pathways and consequently improves cell survival, neurogenesis and synaptic plasticity. However, what is more interesting and has been less discussed upon is how EE could potentially lead to decreased levels of its precursor protein, proNGF. Unlike BDNF, both proNGF and NGF are biologically active [154]. Although proNGF could bind to both TrkA and p75NTR, proNGF has a weaker binding affinity to TrkA compared to p75NTR [155]. Under normal physiological conditions, proNGF is neurotrophic as it could activate TrkA downstream pathways [156]. However, that is not the case in AD patients. As previously mentioned, the conversion of proNGF to mNGF is dysregulated during AD, leading to decreased mNGF production and increased mNGF clearance [157, 158]. Furthermore, it has also been shown that in AD patients, TrkA receptor levels are reduced, with no changes in p75NTR levels being observed [159, 160]. As a result, the increased concentrations of proNGF preferentially bind to p75NTR instead of TrkA, inducing neurodegeneration in the basal forebrain via the activation of the apoptotic c-Jun N-terminal kinase (JNK) pathway (Fig. 2).
The JNK pathway has previously been shown to be implicated in the pathogenesis of AD [161, 162]. This is evidenced by early post-mortem and AD models showing increased JNK concentrations and activity [163, 164]. One of the potential activation signals of the JNK pathway occurs via binding of proNGF to p75NTR. However, in-vitro models have also reported instances of Aβ oligomers activating the JNK pathway [165, 166, 167], resulting in cell apoptosis and abnormal dendritic spine morphology.
Under AD pathological conditions, the increased concentrations of proNGF as well as Aβ oligomers bind to p75NTR, causing the phosphorylation of JNK3, the primary JNK isoform localized in neurons [168]. Activation of the JNK signaling pathway leads to contributes to several phenotypes of AD, and these include (i) increased hyperphosphorylation of tau proteins at serine 422, contributing to increased formation of NFT [169], (ii) increased Aβ peptide and plaque levels as JNK functions as a major kinase for APP phosphorylation at threonine 688 [170], and (iii) increased cell death due to activation of proapoptic proteins (BMF, BIM) [171, 172], inhibition of anti-apoptotic proteins (Bcl2 and Bcl2 homologs) [173, 174], and phosphorylation of c-Jun which mediates cell cycle progression and apoptosis [175, 176].
Although there is a lack of studies regarding the effects of EE on proNGF, conversion of proNGF to NGF could potentially reduce Aβ production, tau hyperphosphorylation, and cell death via downregulation of the JNK pathway. Inhibition of the JNK pathway has previously shown to be effective in delaying the progression of AD hallmarks [177, 178, 179], as well as prevent neuronal cell death induced by JNK pro-apoptotic signaling [180]. Recently, Cho and Kang reported a significant decrease in both proNGF and p75NTR levels in a Parkinson’s Disease mice model following 4 weeks of EE, leading to neuroprotective effects on dopaminergic neurons [181]. However, the effects of EE on proNGF and p75NTR in AD models have yet to be investigated and should become a topic of interest in future EE studies.
Fibroblast growth factors (FGF)
Several reviews have been written regarding the mechanism of action of fibroblast growth factors [182] as well as their involvement in AD [183, 184]. Treatment of AD with different members of FGF have been shown to induce neuroprotective properties in different preclinical models of AD, especially in FGF2. For example, FGF2 has been shown to be a viable treatment method in preclinical models of AD. Chen et al. demonstrated that both low and high molecular weight FGF2 were able to induce neuroprotective effects on astrocytes against Aβ-induced cytotoxicity [185]. Additionally, another study has shown that FGF2 gene transfer is able to restore hippocampal function in a transgenic model of AD mouse, whilst also enhancing Aβ phagocytosis and reducing Aβ production in primary cultured microglia and neurons after FGF2 infection [186]. Furthermore, Katsuori et al. also noted similar results, where FGF2 treatment of APP23 transgenic mice restored spatial memory function, reduced Aβ levels and tau pathologies, and increased astrocytic survival in the dentate gyrus compared to control mice [187]. However, the effects of EE on FGF expression in AD models have been relatively neglected compared to its effects on other neurotrophins. Although not in AD models, both short- and long-term EE has previously been shown to upregulate hippocampal expression of FGF2 in different models of rodent [48, 188, 189]. Furthermore, EE could also promote adult hippocampal neurogenesis through activation of fibroblast growth factor receptors and fibroblast growth receptor substrates [48]. We hypothesize that EE could ameliorate hallmarks of AD by improving FGF levels in the brain. However, more studies have to be conducted in order to better understand the effects of EE on FGF levels in AD models.
Other potential factors which could contribute to the effects of EE include increased expression of neurotrophin-3 and insulin-like growth factor-1 [87], improvements of N-methyl-D-aspartate receptor histone acetylation [190], and changes in metabotropic glutamate receptor mGluRs [191, 192], consequently leading to downstream activation of other undiscussed pathways.
As such, the effects of EE are not confined to a single pathway but rather the activation of multiple downstream pathways working in tandem to produce these effects. To summarize, EE not only delays the progression of AD by affecting its pathogenesis, but also counteracts the neurodegeneration of AD by activating cell regenerative pathways (Fig. 3). As current studies are far and few in between, further investigations in this field hold the promise of more discoveries to be made.
Behavioral Effects of EE and Its Potential Application in Humans
Alongside the progressive decay in cognitive and motor functions, patients with AD also experience gradual alterations in their behavioral patterns. Most notably, they tend to experience behavioral and psychological abnormalities such as psychosis (in the form of hallucinations and delusions), aggressive-like behavior, and depression and anxiety [193]. Normal individuals who experience healthy aging are at no greater risk of developing depression compared to younger adults [194]. In contrast, patients with AD are more likely to display depressive symptoms compared to their healthy counterparts [195]. It is suggested that the stage of AD may influence the risk of developing depression, however results remain inconclusive.
Fortunately, the effects of EE on social behavior have been well documented throughout the past decade. Previous studies have suggested the use of EE in ameliorating anxiety and depressive-like behaviors. Implementation of EE during the early life phase has demonstrated anxiolytic and antidepressant effects on depressed rodents [23, 196]. Moreover, the effects of EE have also been demonstrated in middle and late-life rats [197, 198], implying its effectiveness throughout different stages of life. Additionally, rats exposed to EE displayed reduced anxiety-like behaviors, as seen by increased exploratory behavior during the elevated plus maze and open field tests [23, 199]. This was also seen in a triple transgenic mouse model of AD [200], indicating that EE can also ameliorate AD-induced behavioral alterations.
Although how EE exhibits these antidepressant and anxiolytic properties remains relatively unknown, it is postulated that it could be a result of EE-induced hippocampal neurogenesis [201]. Furthermore, the antidepressant properties of EE could also be a result of the upregulation of neurotrophic factors, such as BDNF and vascular endothelial growth factors, which are responsible in regulating neurogenesis and angiogenesis [20, 202]. Nevertheless, the possibility that EE could also exert these effects via different areas of the brain should not be dismissed. For example, it has been suggested that the anxiolytic effects of EE is associated with down-regulation of amygdalar corticotropin-releasing factor receptor 1 expression [203]. In contrast, another study has claimed that the anxiolytic effects of EE could be modulated by serotonin neurons located in the dorsal raphe nucleus [204].
Recently, an increasing amount of evidence has hinted that EE can improve memory and delay age-related cognitive dysfunctions [205, 206]. Early exposure of EE to AD transgenic rodents was previously found to delay the onset of memory deficits as well as improve neuropathological hallmarks [207, 208, 209]. Moreover, late-life EE was also found to be an effective strategy in improving learning and preserving memory in aged AD transgenic rodents [97, 210]. As the process of learning and memory retention is a primary function of the hippocampus, the increase in hippocampal neurogenesis and improvements in synaptic plasticity could be a key benefit of EE [50, 206]. Furthermore, epigenetic alterations induced by EE, such as modifications to histone acetylation and DNA-methylation, are postulated to lead to a relaxed chromatin structure, improving the expression of genes and proteins essential for learning and memory [97, 208, 211].
While clinical studies are lacking at present, looking at each aspect of EE separately provides us a greater insight into their potential application when it comes to humans. Fundamentally, EE can be broken down into the presence of physical activity, social interaction, and cognitive stimulation [212]. The effects of exercise in the treatment of behavioral disorders is the most well-researched aspect of EE. Based on several meta-analyses and reviews, exposure to physical activities can be an effective method of treatment for depression in adults, rivaling the effects of antidepressant drug therapy [213, 214]. Moreover, treatment of late-life depression in elderly individuals with aerobic exercise seems to also improve depressive-like symptoms [215, 216], with the added benefit of avoiding the side effects of antidepressant medications. Likewise, patients with diagnosed AD who are under long-term exercise regimes had improved cognitive functions [217], likely due to improved vascular blood flow, hippocampal volume, and increased neurogenesis [218, 219]. In addition, recent meta-analyses have also indicated that EE could also benefit memory preservation in older individuals. A meta-analysis comprising of 28 studies (2156 participants) conducted by Zhidong and his team found that physical exercise could improve working memory in older individuals [220]. Aghjayan et al. also conducted a meta-analysis investigating the effects of physical activities in older adults and found that aerobic exercises positively affect episodic memory as well [221]. Similarly, the same effects can also be observed in elderly patients with AD, with Jia et al. reporting that physical activities contribute to their improvement in cognitive functions [222].
Subsequently, the presence and quality of social interactions are also essential for maintaining a healthy state of mind. Accumulating evidence has suggested that social interactions play a key component in delaying or preventing the onset of dementia [223, 224], while the lack thereof has often been associated with a higher risk of dementia in elderly individuals [225, 226]. The presence of social interactions presumably counteracts cognitive deterioration experienced during aging. For example, socially active older individuals were found to have a significantly lower rate of global cognitive decline compared to their infrequently active counterparts [227]. Similar results were also observed in subsequent studies, with decreased cognitive decline being associated with higher social activity [228, 229]. Furthermore, the quality of social interactions should also be taken into account. Daily social interactions, especially more pleasant social interactions, have been shown to improve cognitive function in elderly individuals [230]. A 10-year study has also demonstrated that individuals with poor quality of relationships had nearly double the risk of developing depression [231]. A further cross-sectional study in Switzerland also reported similar findings, with higher quality and frequency of social relationships being associated with lowered risk of developing clinical depression [232].
Cognitive stimulation refers to the involvement of activities generally aimed at enhancing cognitive and social capabilities. In humans, this typically involves activities that aim to stimulate thinking and memory and can come in the form of discussions, word games, puzzles, and general activities [233]. Interestingly, cognitive stimulation therapy (CST) has already been implemented as an alternative treatment method to improve the quality of life of patients with mild-moderate AD. Previous reviews have highlighted the beneficial effects of cognitive stimulation on neuropsychiatric symptoms, including depression, apathy, and anxiety [234]. Furthermore, a randomized controlled trial initiated by Carbone et al. also demonstrated CST as an effective strategy in combating cognitive and emotional deterioration in older patients with mild-moderate dementia [235]. In spite of this, some studies argue that despite the increase in cognitive functions, there were no observable changes in relation to mood and behavior [233, 236, 237]. Moreover, Orrell et al. also noted no significant improvements in the cognitive functions of patients with mild to moderate dementia even after 25 weeks of cognitive stimulation [238].
Implementation of EE in human models will be quite a challenging task. A procedurally uniform EE is hard to introduce for humans due to each individual’s wants and needs, and likely requires a personalized approach if this model is to succeed. Thus far, there has been only one successful implementation of EE in human test subjects. The GAIA project is a pilot study conducted in 2012 to investigate the effects of cognitive stimulation, physical activity, and socialization on patients diagnosed with AD. Specifically, the participants were involved in 1 h of mild aerobic physical exercise, 1 h of cognitive stimulation, and 30 min of social group discussion 5 days a week for 3 months. The group discovered a significant improvement in apathy, anxiety, depression, and quality of life in the active treatment group post-treatment [239]. Although promising, a larger sample size is required to draw more conclusive results. Furthermore, long-term implementation of such a program may be hard to upkeep over time due to high costs in terms of human resources and health facilities.
Discussion and Limitations of Current Studies
The results from current studies regarding the preventive and remedial effects of EE on AD seems promising. As previously discussed, EE not only beneficially improves brain structure and function but also ameliorates behavioral deficits experienced by AD models of rodents. Albeit few, there are several studies reporting contradictory results under similar EE conditions. Presumably, these inconsistencies are not caused by the differences in EE protocols, but rather due to other experimental variables unrelated to the EE paradigm. Previously, EE has been shown to demonstrate gender-specific effects even under the same EE protocol. For instance, SD male rats exposed to 8 weeks of EE showed increased exploratory behavior towards juvenile rats, whereas no differences were found in females [240]. Furthermore, another report has noted that EE had an anxiolytic effect on male mice but had the opposite effects in female mice based on results from the elevated T-maze test [241]. A recent study also found EE to differentially activate neural circuits in FVB/N mice, promoting social interactions in female mice but aggressive behaviors in male mice [242]. Additionally, many studies have also noted the sex-dependent effects of EE in their respective investigations [243, 244].
The duration of EE exposure is also another factor of consideration. For instance, chronic continuous exposure to EE was found to have reduced structural changes in the hippocampus of rats compared to short and periodical exposure [245]. Furthermore, a study conducted by Nguemeni et al. noted that rats subjected to moderate exposure to EE (4 h, 8 h) had significantly increased neurogenesis compared to rats exposed to chronic EE (24 h, 48 h) [246]. Another study conducted by Singhal et al. observed that long-term EE is anxiogenic in transgenic C57BL/6 mice and affects locomotion adversely. In contrast, mice exposed to short-term EE displayed anxiolytic behaviors instead [247].
Additionally, experimenting with different models of AD may yield varying results depending on the genetic backgrounds of the model animals. Using the Tg2576 mice model as an example, no neuronal loss was observed despite having significant deposition of amyloid plaques [248]. In contrast, mice expressing multiple PS1 and APP mutations exhibit a significant neuronal loss in addition to the enhanced deposition of amyloid plaques [249]. One prominent example is when comparing the results conducted by Levi et al. and Rodriguez et al. Exposure of EE to a triple AD transgene model of mice for 6 months led to a beneficial effect on hippocampal neurogenesis [49]. In contrast, the opposite effects can be observed in transgenic apolipoprotein E (APOE) 4 mice under similar EE conditions, whereby EE not only reduced hippocampal neurogenesis but also induced cell apoptosis in APOE4 mice [250].
As discussed previously, the effects of EE are also highly age-dependent. Looking specifically at comparative studies, the effects of EE were found to be age-specific. Harburger et al. demonstrated that continuous exposure to EE for 6 weeks significantly improved spatial memory in aged males (21 months), but had no effect on young (3 months) and middle aged (15 months) C57BL/6 mice [251]. On the other hand, 3 months continuous exposure to EE was found to improve spatial memory in young Wistar male rats (21 days), but did not affect the spatial memory of their aged counterparts (7 months) [252]. In terms of AD model of rodents, early exposure to EE could function as a neuroprotective strategy against the progression of AD, while exposure of EE during mid and late-life models of AD have varying degrees of effectiveness. Presumably, this could be due to the progressive decline in neuroplasticity following aging, leading to decreased cognitive flexibility and alterations in structural plasticity [253]. Early exposure to EE plays a key part in demonstrating its effects. Deposition of Aβ starts between the age of 40–50 and precedes the onset of AD symptoms by over 20 years [254]. Presumably, the neuronal damage induced by Aβ deposition during the preclinical/early stages has yet to be significant and could be rescued by the counteracting effects of EE. On the other hand, the effectiveness of EE during the mid and late stages of AD could be diminished, due in part to the extensive neurotoxicity caused by the culmination of Aβ levels in the brain. Furthermore, exposure to EE could lead to the downstream effects of multiple molecular cascades. How EE interacts and simultaneously affects multiple downstream pathways still remains relatively unknown and could likely cause variances in results.
Although EE impacts the brain beneficially, the differences in the degree of effectiveness complicates the process of pinpointing the importance of the different EE aspects. To better understand this, it is first important to establish how different elements of EE contribute to certain effects. By far, the most unique aspect of EE is the presence of novel objects to promote cognitive stimulation. This typically comes in the form of toys, shelters, hideouts, mazes, and provision of objects of different materials, sizes, and shapes. Object rearrangement was also encouraged to further promote cognitive stimulation in rats. However, the number of objects and frequency of object rearrangement may vary according to the experimental protocol used. The effects of cognitive stimulation on the hippocampus remain relatively unclear. The establishment of EE in most studies have included both running wheels and novel objects in their experimental design. However, to fully understand the effects of cognitive stimulation through introduction of novel objects, some studies have excluded the running wheel to prevent physical enrichment induced by it. Animals exposed to novel toys have previously been shown to improve learning and memory only if the animals actively manipulated the object [255]. Similarly, animals living in an enriched with only the presence of toys had increased learning flexibility in the Morris maze test, owing to the increase in adult neurogenesis as a result of the novel environment [45]. In contrast, another study demonstrated that EE, in the absence of running wheels, failed to induce hippocampal neurogenesis and improve cognitive performance, even in the presence of a complex environment [256]. Furthermore, cognitive stimulation of adult female mice significantly affected synaptophysin levels in the neocortex and hippocampus compared to the control group [257], which could contribute to synaptogenesis in hippocampal neurons [258, 259]. However, the increase in synaptophysin did not subsequently lead to an improvement in spatial working memory based on the water radial arm maze test conducted [257]. Synaptogenesis, angiogenesis, cell proliferation and cell survival were also improved in response to being housed in a complex environment [150, 260]. Interestingly, the beneficial effects of EE also scale with the degree of enrichment, with the increased number of enrichment items corresponding to increased benefits in stereotypic behavior, behavioral measures of anxiety, growth, and stress physiology [261]. Hence, we postulate that the complexity of the cage environment and cognitive stimulation could affect memory consolidation and potentially improve synaptic plasticity. However, cognitive stimulation did not seem to contribute to hippocampal neurogenesis based on pre-existing literature.
Physical enrichment, on the other hand, has been suggested to be the most important aspect of EE based on rodent studies. The inclusion of a running wheel is often an important factor in a typically enriched cage. Furthermore, certain toys, such as ladders and stairs could also stimulate anaerobic physical activity in rodents to a certain extent. Previous studies have already discussed the neuroprotective properties of physical exercise on the hippocampus, and these include increased neurogenesis, size and volume [262], enhanced neuroplasticity [218], and promote the expression of neurotrophic factors [263, 264]. Furthermore, several studies argue that the sole presence of novel toys without the presence of running wheel is insufficient in promoting beneficial effects to the hippocampus. Mustroph et al. demonstrated that hippocampal neurogenesis were similar between male mice exposed to physical enrichment compared to mice exposed to EE. Furthermore, the group also noted that EE did not improve spatial learning based on the Morris water maze test [256]. Another study also noted the importance of physical enrichment in EE, whereby they concluded that physical exercise is the critical factor in promoting adult hippocampal neurogenesis through the release of neurotrophin factors [265]. However, it should still be noted that the presence of both physical exercise and presence of a novel environment could lead to an additive effect when promoting hippocampal neurogenesis. As reported, the group noted a 30% increase new neurons as compared to either stimulus alone [266].
The last key element being enriched in EE is the promotion of social interactions. In EE, multiple number of rodents are caged at a time, however the number of rodents per cage differs based on the protocol. The importance of the social component has led to several discussions throughout the last few decades. The presence of social interactions has previously been shown to induce hippocampal neurogenesis and improve synaptic plasticity. Lu et al. demonstrated that rats reared in group housing for 4—8 weeks had increased newborn neurons in the dentate gyrus and increased LTP in the CA1 region compared to their socially isolated counterparts [267]. Subsequently, the effects induced by social isolation could be reversed through subsequent group rearing. Similarly, the presence of social interactions was also found to improve hippocampal cell proliferation and neurogenesis, but is unable to affect learning capabilities by itself [268]. Perhaps what is considered essential in the EE paradigm is the presence of social interactions rather than the degree of social enrichment (i.e., number of animals housed per cage). For example, the effects of EE on LTP were only notable in the presence of a social environment, on the other hand, EE in socially isolated rats did not induce LTP in the hippocampus [269]. Moreover, one of the earliest studies conducted by Rosenzweig et al. suggested that social interactions alone cannot account for the cerebral effects of EE [14], with subsequent studies agreeing to this notion [191, 207, 270]. Interestingly enough, it was shown that increased group housing (n = 12 per cage), in the absence of physical or cognitive stimulation, could also further enhance adult hippocampal neurogenesis in adult female mice compared to the control group (n = 6 per cage) [271]. The presence of a social environment has been shown to improve neurogenesis and synaptic plasticity in the hippocampus. However, more studies have to be conducted to evaluate the effectiveness of social enrichment, rather than the presence of social interactions, in the EE paradigm.
Taken altogether, our understanding of current literature points to physical enrichment as the primary instigator of the effects of EE. Even so, the presence of both cognitive stimulation and social interactions are important to facilitate and to potentially further amplify these effects. However, additional studies need to be conducted to determine whether enrichment of the cognitive and social aspects of EE could improve hippocampal conditions. One potential approach is to study the effects of individual toys (ladders, stairs, plastic objects, hideouts) on brain structures which could further lead to a study investigating the combinational effects of different toys on the brain.
Despite the numerous findings of EE, comparison of effects between different studies is indeed limited. This is particularly due to the fact that the degree of enrichment for the physical, social and cognitive aspects of EE are vastly distinct between each study. For example, the amount of running wheels between certain EE protocols are different, with some studies having zero [45, 61, 272], one [46, 50, 250], or two or more running wheels [48, 270] in their study. Additionally, the amount of animals housed per group could also vary with some having up to 40 per group housing [273]. Potentially, this could create instances of overcrowding, whereby it could induce detrimental effects to the animals instead [274, 275]. Furthermore, the degree of cage of enrichment, i.e., cage size as well as the number of novel objects and the frequency of repositioning said toys also varies between studies, with the increased number of enrichment items corresponding to increased benefits [261].
Hence, in order to effectively study the effects of EE, a standardized protocol has to first be established. At this current state, it is difficult to establish a comparison of results between different EE studies due to the variance in EE protocols. The establishment of a standardized protocol not only allows the reproducibility of results to be more consistent but also allows subsequent studies to identify which variables are essential when investigating the effects of EE.
Conclusion and Future Directions
Based on pre-existing studies, environmental enrichment presents itself as an effective neuroprotective strategy in the prevention of Alzheimer’s disease via the modulation of multiple pathways. However, how these individual pathways interact with each other during and after exposure to environmental enrichment remains relatively unknown. Future studies regarding how environmental enrichment affects multiple pathways would be essential to further understand the molecular mechanisms behind it.
Although this review has primarily focused on the effects of EE on the hippocampus. It should not be dismissed that EE also exhibits its effects via other areas of the brain. The amygdala, prefrontal cortex, and entorhinal cortex could potentially be key structures due to their susceptibility to neurodegeneration.
Implementation of EE in human models will also present itself as a rather challenging task. Although its effectiveness has been shown in animal models, the clinical application of EE in humans has yet to be widely demonstrated. Hence, it is essential to establish a better understanding of the mechanisms of environmental enrichment before it can be a viable non-pharmacological alternative for the prevention and potential treatment of AD in human patients.
Data Availability
Not applicable.
References
United Nations, Department of Economic and Social Affairs, Population Division (2019) World population ageing 2019: highlights (ST/ESA/SER.A/430). https://doi.org/10.18356/9df3caed-en
Tejada-Vera B (2013) Mortality from Alzheimer’s disease in the United States: data for 2000 and 2010. NCHS Data Brief (116):1–8
(2021) 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 17:327–406
Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541–5554. https://doi.org/10.2147/IJN.S200490
Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s Disease: causes and treatment. Molecules 25(24):5789. https://doi.org/10.3390/molecules25245789
Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 80(19):1778–1783
Bisht K, Sharma K, Tremblay M-È (2018) Chronic stress as a risk factor for Alzheimer’s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiol stress 9:9–21
Bellenguez C, Grenier-Boley B, Lambert J-C (2020) Genetics of Alzheimer’s disease: where we are, and where we are going. Curr Opin Neurobiol 61:40–48
Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S et al (2016) Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 12(3):292–323. https://doi.org/10.1016/j.jalz.2016.02.002
Wattmo C, Minthon L, Wallin AK (2016) Mild versus moderate stages of Alzheimer’s disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers Res Ther 8(1):7. https://doi.org/10.1186/s13195-016-0174-1
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413–446. https://doi.org/10.1016/S0140-6736(20)30367-6
Briggs R, Kennelly SP, O’Neill D (2016) Drug treatments in Alzheimer’s disease. Clin Med (Lond) 16(3):247–253. https://doi.org/10.7861/clinmedicine.16-3-247
Hebb DO (1947) The effects of early experience on problem-solving at maturity. Am Psychol 2:306–307
Rosenzweig MR, Bennett EL, Hebert M, Morimoto H (1978) Social grouping cannot account for cerebral effects of enriched environments. Brain Res 153(3):563–576. https://doi.org/10.1016/0006-8993(78)90340-2
Coleman K, Novak MA (2017) Environmental Enrichment in the 21st Century. ILAR J 58(2):295–307. https://doi.org/10.1093/ilar/ilx008
Stewart K, Bayne K, Reuter J (2004) Environmental enrichment for laboratory animals. Laboratory Animal Medicine and Management. International Veterinary Information Service, New York, pp 39–44. Retrieved from https://www.ivis.org/library/laboratory-animal-medicine-and-management/environmental-enrichment-for-laboratoryanimals
Jin X, Li T, Zhang L, Ma J, Yu L, Li C et al (2017) Environmental enrichment improves spatial learning and memory in vascular dementia rats with activation of Wnt/beta-catenin signal pathway. Med Sci Monit 23:207–15. https://doi.org/10.12659/msm.902728
Soares RO, Horiquini-Barbosa E, Almeida SS, Lachat JJ (2017) Environmental enrichment protects spatial learning and hippocampal neurons from the long-lasting effects of protein malnutrition early in life. Behav Brain Res 335:55–62. https://doi.org/10.1016/j.bbr.2017.08.012
Carbia PS, Brown C (2019) Environmental enrichment influences spatial learning ability in captive-reared intertidal gobies (Bathygobius cocosensis). Anim Cogn 22(1):89–98. https://doi.org/10.1007/s10071-018-1225-8
Jha S, Dong B, Sakata K (2011) Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV. Transl Psychiatry 1(9):e40-e
Grippo AJ, Ihm E, Wardwell J, McNeal N, Scotti M-AL, Moenk DA et al (2014) The effects of environmental enrichment on depressive-and anxiety-relevant behaviors in socially isolated prairie voles. Psychosom Med 76(4):277
Seong HH, Park JM, Kim YJ (2018) Antidepressive effects of environmental enrichment in chronic stress-induced depression in rats. Biol Res Nurs 20(1):40–48. https://doi.org/10.1177/1099800417730400
Gong X, Chen Y, Chang J, Huang Y, Cai M, Zhang M (2018) Environmental enrichment reduces adolescent anxiety- and depression-like behaviors of rats subjected to infant nerve injury. J Neuroinflammation 15(1):262. https://doi.org/10.1186/s12974-018-1301-7
Speisman RB, Kumar A, Rani A, Pastoriza JM, Severance JE, Foster TC et al (2013) Environmental enrichment restores neurogenesis and rapid acquisition in aged rats. Neurobiol Aging 34(1):263–274. https://doi.org/10.1016/j.neurobiolaging.2012.05.023
de Siqueira FdCC, de Almeida MNF, Felício APG, Fadel AC, de Jesus Silva D, Borralho TG et al (2013) Enriched environment and masticatory activity rehabilitation recover spatial memory decline in aged mice. BMC Neurosci 14(1):1–9
Van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ (2000) Delaying the onset of Huntington’s in mice. Nature 404(6779):721–722
Hockly E, Cordery PM, Woodman B, Mahal A, Van Dellen A, Blakemore C et al (2002) Environmental enrichment slows disease progression in R6/2 Huntington’s disease mice. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 51(2):235–242
Spires TL, Grote HE, Varshney NK, Cordery PM, Van Dellen A, Blakemore C et al (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington’s disease, indicating a possible disease mechanism. J Neurosci 24(9):2270–2276
Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR (2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 62(12):1220–1227
Levi O, Jongen-Relo AL, Feldon J, Roses AD, Michaelson DM (2003) ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis 13(3):273–282
Wahl D, Solon-Biet SM, Cogger VC, Fontana L, Simpson SJ, Le Couteur DG et al (2019) Aging, lifestyle and dementia. Neurobiol Dis 130:104481
Shepherd A, Zhang TD, Zeleznikow-Johnston AM, Hannan AJ, Burrows EL (2018) Transgenic mouse models as tools for understanding how increased cognitive and physical stimulation can improve cognition in Alzheimer’s disease. Brain Plasticity 4(1):127–150
Llorens-Martín M (2018) Exercising new neurons to vanquish Alzheimer disease. Brain Plasticity 4(1):111–126
Robertson IH (2013) A noradrenergic theory of cognitive reserve: implications for Alzheimer’s disease. Neurobiol Aging 34(1):298–308
Cutuli D, Landolfo E, Petrosini L, Gelfo F (2022) Environmental enrichment effects on the brain-derived neurotrophic factor expression in healthy condition, Alzheimer’s disease, and other neurodegenerative disorders. J Alzheimers Dis 85:975–992
Alanko V, Udeh-Momoh C, Kivipelto M, Sandebring-Matton A (2022) Mechanisms underlying non-pharmacological dementia prevention strategies: a translational perspective. J Prev Alzheimers Dis 9(1):3–11
Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM et al (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120(5):701–713. https://doi.org/10.1016/j.cell.2005.01.015
Balthazar J, Schöwe NM, Cipolli GC, Buck HS, Viel TA (2018) Enriched environment significantly reduced senile plaques in a transgenic mice model of Alzheimer’s disease, improving memory. Front Aging Neurosci 10:288
Anand KS, Dhikav V (2012) Hippocampus in health and disease: an overview. Ann Indian Acad Neurol 15(4):239–246. https://doi.org/10.4103/0972-2327.104323
Criscuolo C, Fontebasso V, Middei S, Stazi M, Ammassari-Teule M, Yan SS et al (2017) Entorhinal cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer’s disease mouse model. Sci Rep 7(1):1–15
Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ et al (2009) MRI of hippocampal volume loss in early Alzheimer’s disease in relation to ApoE genotype and biomarkers. Brain 132(Pt 4):1067–1077. https://doi.org/10.1093/brain/awp007
McRae-McKee K, Evans S, Hadjichrysanthou C, Wong MM, de Wolf F, Anderson RM (2019) Combining hippocampal volume metrics to better understand Alzheimer’s disease progression in at-risk individuals. Sci Rep 9(1):7499. https://doi.org/10.1038/s41598-019-42632-w
Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19(R1):R12-20. https://doi.org/10.1093/hmg/ddq160
Moreno-Jiménez EP, Flor-García M, Terreros-Roncal J, Rábano A, Cafini F, Pallas-Bazarra N et al (2019) Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med 25(4):554–560
Garthe A, Roeder I, Kempermann G (2016) Mice in an enriched environment learn more flexibly because of adult hippocampal neurogenesis. Hippocampus 26(2):261–271
Ramírez-Rodríguez G, Ocaña-Fernández M, Vega-Rivera N, Torres-Pérez O, Gómez-Sánchez A, Estrada-Camarena E et al (2014) Environmental enrichment induces neuroplastic changes in middle age female BalbC mice and increases the hippocampal levels of BDNF, p-Akt and p-MAPK1/2. Neuroscience 260:158–170
Olson AK, Eadie BD, Ernst C, Christie BR (2006) Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways. Hippocampus 16(3):250–260. https://doi.org/10.1002/hipo.20157
Grońska-Pęski M, Gonçalves JT, Hébert JM (2021) Enriched environment promotes adult hippocampal neurogenesis through FGFRs. J Neurosci 41(13):2899–2910
Rodriguez JJ, Noristani HN, Olabarria M, Fletcher J, Somerville TDD, Yeh CY et al (2011) Voluntary running and environmental enrichment restores impaired hippocampal neurogenesis in a triple transgenic mouse model of Alzheimer’s disease. Curr Alzheimer Res 8(7):707–17
Valero J, España J, Parra-Damas A, Martín E, Rodríguez-Álvarez J, Saura CA (2011) Short-term environmental enrichment rescues adult neurogenesis and memory deficits in APPSw, Ind transgenic mice. PLoS One 6(2):e16832
Llorens-Martin M, Fuster-Matanzo A, Teixeira CM, Jurado-Arjona J, Ulloa F, Defelipe J et al (2013) GSK-3beta overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo. Mol Psychiatry 18(4):451–460. https://doi.org/10.1038/mp.2013.4
Hüttenrauch M, Salinas G, Wirths O (2016) Effects of long-term environmental enrichment on anxiety, memory, hippocampal plasticity and overall brain gene expression in C57BL6 mice. Front Mol Neurosci 9:62
Beauquis J, Roig P, De Nicola AF, Saravia F (2010) Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice. PLoS One 5(11):e13993. https://doi.org/10.1371/journal.pone.0013993
Stuchlik A (2014) Dynamic learning and memory, synaptic plasticity and neurogenesis: an update. Front Behav Neurosci 8:106. https://doi.org/10.3389/fnbeh.2014.00106
Shankar GM, Walsh DM (2009) Alzheimer’s disease: synaptic dysfunction and Abeta. Mol Neurodegener 4(1):48. https://doi.org/10.1186/1750-1326-4-48
Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N et al (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55(5):697–711. https://doi.org/10.1016/j.neuron.2007.07.025
Lante F, Chafai M, Raymond EF, Pereira AR, Mouska X, Kootar S et al (2015) Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer’s disease. Neuropsychopharmacology 40(7):1772–1781. https://doi.org/10.1038/npp.2015.25
Song S, Wang X, Sava V, Weeber EJ, Sanchez-Ramos J (2014) In vivo administration of granulocyte colony-stimulating factor restores long-term depression in hippocampal slices prepared from transgenic APP/PS1 mice. J Neurosci Res 92(8):975–980. https://doi.org/10.1002/jnr.23378
Subramanian J, Savage JC, Tremblay ME (2020) Synaptic loss in Alzheimer’s Disease: mechanistic insights provided by two-photon in vivo imaging of transgenic mouse models. Front Cell Neurosci 14:592607. https://doi.org/10.3389/fncel.2020.592607
Jackson J, Jambrina E, Li J, Marston H, Menzies F, Phillips K et al (2019) Targeting the synapse in alzheimer’s disease. Front Neurosci 13:735. https://doi.org/10.3389/fnins.2019.00735
Stein LR, O’Dell KA, Funatsu M, Zorumski CF, Izumi Y (2016) Short-term environmental enrichment enhances synaptic plasticity in hippocampal slices from aged rats. Neuroscience 329:294–305. https://doi.org/10.1016/j.neuroscience.2016.05.020
Manahan-Vaughan D, Buschler A (2012) Brief environmental enrichment elicits metaplasticity of hippocampal synaptic potentiation in vivo. Front Behav Neurosci 6:85
Morelli E, Ghiglieri V, Pendolino V, Bagetta V, Pignataro A, Fejtova A et al (2014) Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. Exp Neurol 261:320–327. https://doi.org/10.1016/j.expneurol.2014.05.010
Wang CJ, Wu Y, Zhang Q, Yu KW, Wang YY (2019) An enriched environment promotes synaptic plasticity and cognitive recovery after permanent middle cerebral artery occlusion in mice. Neural Regen Res 14(3):462–469. https://doi.org/10.4103/1673-5374.245470
Wei Z, Meng X, El Fatimy R, Sun B, Mai D, Zhang J et al (2020) Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways. Neurobiol Dis 134:104617
Hu YS, Xu P, Pigino G, Brady ST, Larson J, Lazarov O (2010) Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer’s disease-linked APPswe/PS1DeltaE9 mice. FASEB J 24(6):1667–1681. https://doi.org/10.1096/fj.09-136945
Selvi Y, Gergerlioglu HS, Akbaba N, Oz M, Kandeger A, Demir EA et al (2017) Impact of enriched environment on production of tau, amyloid precursor protein and amyloid-beta peptide in high-fat and high-sucrose-fed rats. Acta Neuropsychiatr 29(5):291–298. https://doi.org/10.1017/neu.2016.63
Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T et al (2018) Phosphorylation of different tau sites during progression of Alzheimer’s disease. Acta Neuropathol Commun 6(1):52. https://doi.org/10.1186/s40478-018-0557-6
Herring A, Lewejohann L, Panzer AL, Donath A, Kroll O, Sachser N et al (2011) Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Neurobiol Dis 42(3):530–538. https://doi.org/10.1016/j.nbd.2011.03.007
Xu H, Gelyana E, Rajsombath M, Yang T, Li S, Selkoe D (2016) Environmental Enrichment potently prevents microglia-mediated neuroinflammation by human amyloid beta-protein oligomers. J Neurosci 36(35):9041–9056. https://doi.org/10.1523/JNEUROSCI.1023-16.2016
Montarolo F, Parolisi R, Hoxha E, Boda E, Tempia F (2013) Early enriched environment exposure protects spatial memory and accelerates amyloid plaque formation in APPSwe/PS1L166P mice. PLoS One 8(7):e69381
Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V et al (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer’s disease. J Neurosci 25(21):5217–5224. https://doi.org/10.1523/JNEUROSCI.5080-04.2005
Jeong YH, Kim JM, Yoo J, Lee SH, Kim HS, Suh YH (2011) Environmental enrichment compensates for the effects of stress on disease progression in Tg2576 mice, an Alzheimer’s disease model. J Neurochem 119(6):1282–1293. https://doi.org/10.1111/j.1471-4159.2011.07514.x
Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H (2004) Environmental enrichment improves cognition in aged Alzheimer’s transgenic mice despite stable beta-amyloid deposition. NeuroReport 15(11):1751–1754. https://doi.org/10.1097/01.wnr.0000137183.68847.4e
Stuart KE, King AE, Fernandez-Martos CM, Dittmann J, Summers MJ, Vickers JC (2017) Mid-life environmental enrichment increases synaptic density in CA1 in a mouse model of Abeta-associated pathology and positively influences synaptic and cognitive health in healthy ageing. J Comp Neurol 525(8):1797–1810. https://doi.org/10.1002/cne.24156
Fulopova B, Stuart KE, Bennett W, Bindoff A, King AE, Vickers JC et al (2021) Regional differences in beta amyloid plaque deposition and variable response to midlife environmental enrichment in the cortex of APP/PS1 mice. J Comp Neurol 529(8):1849–1862. https://doi.org/10.1002/cne.25060
Mainardi M, Di Garbo A, Caleo M, Berardi N, Sale A, Maffei L (2014) Environmental enrichment strengthens corticocortical interactions and reduces amyloid-beta oligomers in aged mice. Front Aging Neurosci 6:1. https://doi.org/10.3389/fnagi.2014.00001
Kazlauckas V, Pagnussat N, Mioranzza S, Kalinine E, Nunes F, Pettenuzzo L et al (2011) Enriched environment effects on behavior, memory and BDNF in low and high exploratory mice. Physiol Behav 102(5):475–480. https://doi.org/10.1016/j.physbeh.2010.12.025
Kondo M, Takei Y, Hirokawa N (2012) Motor protein KIF1A is essential for hippocampal synaptogenesis and learning enhancement in an enriched environment. Neuron 73(4):743–757
Xu X-F, Li T, Wang D-D, Chen B, Wang Y, Chen Z-Y (2015) Integrin-linked kinase is essential for environmental enrichment enhanced hippocampal neurogenesis and memory. Sci Rep 5(1):1–16
Dandi Ε, Kalamari A, Touloumi O, Lagoudaki R, Nousiopoulou E, Simeonidou C et al (2018) Beneficial effects of environmental enrichment on behavior, stress reactivity and synaptophysin/BDNF expression in hippocampus following early life stress. Int J Dev Neurosci 67:19–32
Torasdotter M, Metsis M, Henriksson BG, Winblad B, Mohammed AH (1998) Environmental enrichment results in higher levels of nerve growth factor mRNA in the rat visual cortex and hippocampus. Behav Brain Res 93(1–2):83–90. https://doi.org/10.1016/s0166-4328(97)00142-3
Gelfo F, Cutuli D, Foti F, Laricchiuta D, De Bartolo P, Caltagirone C et al (2011) Enriched environment improves motor function and increases neurotrophins in hemicerebellar lesioned rats. Neurorehabil Neural Repair 25(3):243–252. https://doi.org/10.1177/1545968310380926
Miranda M, Morici JF, Zanoni MB, Bekinschtein P (2019) Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci 13:363. https://doi.org/10.3389/fncel.2019.00363
Lu B (2003) Pro-region of neurotrophins: role in synaptic modulation. Neuron 39(5):735–738. https://doi.org/10.1016/s0896-6273(03)00538-5
Horii-Hayashi N, Yoshikawa M, Matsusue Y, Ishizaka S, Nishi M, Wanaka A (2011) Environmental stimulation changes tissue-type plasminogen activator activity in the adult mouse hippocampus. Neurochem Int 58(1):1–4. https://doi.org/10.1016/j.neuint.2010.10.007
Hu YS, Long N, Pigino G, Brady ST, Lazarov O (2013) Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3beta, neurotrophin-3 and CREB signaling. PLoS One 8(5):e64460. https://doi.org/10.1371/journal.pone.0064460
Xu L, Zhu L, Zhu L, Chen D, Cai K, Liu Z et al (2021) Moderate Exercise combined with enriched environment enhances learning and memory through BDNF/TrkB Signaling pathway in rats. Int J Environ Res Public Health 18(16):8283
Bengoetxea H, Rico-Barrio I, Ortuzar N, Murueta-Goyena A, Lafuente JV (2018) Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway. Mol Neurobiol 55(1):43–59
Singh S, Singh TG (2020) Role of Nuclear Factor Kappa B (NF-kappaB) Signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918–935. https://doi.org/10.2174/1570159X18666200207120949
Ju Hwang C, Choi D-Y, Park MH, Hong JT (2019) NF-κB as a key mediator of brain inflammation in Alzheimer’s disease. CNS Neurol Disord Drug Targets 18(1):3–10
Davies DA (2021) The role of APOE and NF-κB in Alzheimer’s disease. Immuno 1(4):391–399
Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M et al (2012) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease. Int J Neuropsychopharmacol 15(1):77–90. https://doi.org/10.1017/S1461145711000149
Chami L, Buggia-Prévot V, Duplan E, Delprete D, Chami M, Peyron J-F et al (2012) Nuclear factor-κB regulates βAPP and β-and γ-secretases differently at physiological and supraphysiological Aβ concentrations. J Biol Chem 287(29):24573–24584
Kaltschmidt B, Kaltschmidt C (2015) NF-KappaB in long-term memory and structural plasticity in the adult mammalian brain. Front Mol Neurosci 8:69. https://doi.org/10.3389/fnmol.2015.00069
Bai D, Ueno L, Vogt PK (2009) Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int J Cancer 125(12):2863–2870. https://doi.org/10.1002/ijc.24748
Neidl R, Schneider A, Bousiges O, Majchrzak M, Barbelivien A, de Vasconcelos AP et al (2016) Late-life environmental enrichment induces acetylation events and nuclear factor kappab-dependent regulations in the hippocampus of aged rats showing improved plasticity and learning. J Neurosci 36(15):4351–4361. https://doi.org/10.1523/JNEUROSCI.3239-15.2016
Grinan-Ferre C, Puigoriol-Illamola D, Palomera-Avalos V, Perez-Caceres D, Companys-Alemany J, Camins A et al (2016) Environmental Enrichment modified epigenetic mechanisms in SAMP8 mouse hippocampus by reducing oxidative stress and inflammaging and achieving neuroprotection. Front Aging Neurosci 8:241. https://doi.org/10.3389/fnagi.2016.00241
Nakano M, Kubota K, Hashizume S, Kobayashi E, Chikenji TS, Saito Y et al (2020) An enriched environment prevents cognitive impairment in an Alzheimer’s disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus. Brain Behav Immun Health 9:100149. https://doi.org/10.1016/j.bbih.2020.100149
Kubota K, Nakano M, Kobayashi E, Mizue Y, Chikenji T, Otani M et al (2018) An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One 13(9):e0204252. https://doi.org/10.1371/journal.pone.0204252
Cordner Z, Tamashiro K (2016) Effects of chronic variable stress on cognition and Bace1 expression among wild-type mice. Transl Psychiatry 6(7):e854-e
Qiao A, Li J, Hu Y, Wang J, Zhao Z (2021) Reduction BACE1 expression via suppressing NF-kappaB mediated signaling by Tamibarotene in a mouse model of Alzheimer’s disease. IBRO Neurosci Rep 10:153–160. https://doi.org/10.1016/j.ibneur.2021.02.004
Lauretti E, Dincer O, Pratico D (2020) Glycogen synthase kinase-3 signaling in Alzheimer’s disease. Biochim Biophys Acta Mol Cell Res 1867(5):118664. https://doi.org/10.1016/j.bbamcr.2020.118664
Griebel G, Stemmelin J, Lopez-Grancha M, Boulay D, Boquet G, Slowinski F et al (2019) The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents. Sci Rep 9(1):18045. https://doi.org/10.1038/s41598-019-54557-5
Sereno L, Coma M, Rodriguez M, Sanchez-Ferrer P, Sanchez MB, Gich I et al (2009) A novel GSK-3beta inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo. Neurobiol Dis 35(3):359–367. https://doi.org/10.1016/j.nbd.2009.05.025
Smillie KJ, Pawson J, Perkins EM, Jackson M, Cousin MA (2013) Control of synaptic vesicle endocytosis by an extracellular signalling molecule. Nat Commun 4(1):2394. https://doi.org/10.1038/ncomms3394
Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A et al (2013) Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123(1):224–235. https://doi.org/10.1172/JCI64516
Morales-Garcia JA, Luna-Medina R, Alonso-Gil S, Sanz-Sancristobal M, Palomo V, Gil C et al (2012) Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo. ACS Chem Neurosci 3(11):963–971. https://doi.org/10.1021/cn300110c
Guo W, Murthy AC, Zhang L, Johnson EB, Schaller EG, Allan AM et al (2012) Inhibition of GSK3beta improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome. Hum Mol Genet 21(3):681–691. https://doi.org/10.1093/hmg/ddr501
Pardo M, King MK, Perez-Costas E, Melendez-Ferro M, Martinez A, Beurel E et al (2015) Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3. Front Behav Neurosci 9:55. https://doi.org/10.3389/fnbeh.2015.00055
Yang L, Wang H, Liu L, Xie A (2018) The role of insulin/IGF-1/PI3K/Akt/GSK3beta signaling in Parkinson’s disease dementia. Front Neurosci 12:73. https://doi.org/10.3389/fnins.2018.00073
Esvald EE, Tuvikene J, Sirp A, Patil S, Bramham CR, Timmusk T (2020) CREB Family transcription factors are major mediators of BDNF transcriptional autoregulation in cortical neurons. J Neurosci 40(7):1405–1426. https://doi.org/10.1523/JNEUROSCI.0367-19.2019
Wang L, Cao M, Pu T, Huang H, Marshall C, Xiao M (2018) Enriched physical environment attenuates spatial and social memory impairments of aged socially isolated mice. Int J Neuropsychopharmacol 21(12):1114–1127. https://doi.org/10.1093/ijnp/pyy084
Peltier J, O’Neill A, Schaffer DV (2007) PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67(10):1348–1361. https://doi.org/10.1002/dneu.20506
Gandolfi D, Cerri S, Mapelli J, Polimeni M, Tritto S, Fuzzati-Armentero MT et al (2017) Activation of the CREB/c-Fos pathway during long-term synaptic plasticity in the cerebellum granular layer. Front Cell Neurosci 11:184. https://doi.org/10.3389/fncel.2017.00184
Zhang XQ, Mu JW, Wang HB, Jolkkonen J, Liu TT, Xiao T et al (2016) Increased protein expression levels of pCREB, BDNF and SDF-1/CXCR4 in the hippocampus may be associated with enhanced neurogenesis induced by environmental enrichment. Mol Med Rep 14(3):2231–2237
Serita T, Fukushima H, Kida S (2017) Constitutive activation of CREB in mice enhances temporal association learning and increases hippocampal CA1 neuronal spine density and complexity. Sci Rep 7(1):42528. https://doi.org/10.1038/srep42528
Du L-L, Wang L, Yang X-F, Wang P, Li X-H, Chai D-M et al (2017) Transient receptor potential-canonical 1 is essential for environmental enrichment-induced cognitive enhancement and neurogenesis. Mol Neurobiol 54(3):1992–2002
Rojas-Carvajal M, Sequeira-Cordero A, Brenes JC (2020) Neurobehavioral Effects of restricted and unpredictable environmental enrichment in rats. Front Pharmacol 11:674. https://doi.org/10.3389/fphar.2020.00674
Chen MJ, Russo-Neustadt AA (2009) Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent. Hippocampus 19(10):962–972
Shen H, Tong L, Balazs R, Cotman CW (2001) Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus. Neuroscience 107(2):219–229. https://doi.org/10.1016/s0306-4522(01)00315-3
Sanchez-Alegria K, Flores-Leon M, Avila-Munoz E, Rodriguez-Corona N, Arias C (2018) PI3K signaling in neurons: a central node for the control of multiple functions. Int J Mol Sci 19(12):3725. https://doi.org/10.3390/ijms19123725
Sanphui P, Biswas S (2013) FoxO3a is activated and executes neuron death via Bim in response to β-amyloid. Cell Death Dis 4(5):e625-e
Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF (2015) Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35(6):600–604. https://doi.org/10.3109/10799893.2015.1030412
Koga Y, Tsurumaki H, Aoki-Saito H, Sato M, Yatomi M, Takehara K et al (2019) Roles of cyclic AMP Response element binding activation in the ERK1/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system, osteoclast differentiation and mucin and cytokine production. Int J Mol Sci 20(6):1346. https://doi.org/10.3390/ijms20061346
Ducker C, Chow LKY, Saxton J, Handwerger J, McGregor A, Strahl T et al (2019) De-ubiquitination of ELK-1 by USP17 potentiates mitogenic gene expression and cell proliferation. Nucleic Acids Res 47(9):4495–4508. https://doi.org/10.1093/nar/gkz166
Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12(1):9–18. https://doi.org/10.1038/sj.cr.7290105
Karelina K, Hansen KF, Choi YS, DeVries AC, Arthur JS, Obrietan K (2012) MSK1 regulates environmental enrichment-induced hippocampal plasticity and cognitive enhancement. Learn Mem 19(11):550–560. https://doi.org/10.1101/lm.025775.112
Huang FL, Huang KP, Wu J, Boucheron C (2006) Environmental enrichment enhances neurogranin expression and hippocampal learning and memory but fails to rescue the impairments of neurogranin null mutant mice. J Neurosci 26(23):6230–6237. https://doi.org/10.1523/JNEUROSCI.1182-06.2006
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36(11):1461–1473. https://doi.org/10.1038/onc.2016.304
Palomer E, Buechler J, Salinas PC (2019) Wnt signaling deregulation in the aging and Alzheimer’s brain. Front Cell Neurosci 13:227. https://doi.org/10.3389/fncel.2019.00227
Aghaizu ND, Jin H, Whiting PJ (2020) Dysregulated Wnt signalling in the Alzheimer’s brain. Brain Sci 10(12):902. https://doi.org/10.3390/brainsci10120902
Jia L, Piña-Crespo J, Li Y (2019) Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease. Mol Brain 12(1):1–11
Martinez-Font E, Pérez-Capó M, Ramos R, Felipe I, Garcías C, Luna P et al (2020) Impact of Wnt/β-Catenin inhibition on cell proliferation through CDC25A downregulation in soft tissue sarcomas. Cancers 12(9):2556
Bilir B, Kucuk O, Moreno CS (2013) Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med 11(1):280. https://doi.org/10.1186/1479-5876-11-280
Gao L, Chen B, Li J, Yang F, Cen X, Liao Z et al (2017) Wnt/beta-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms. PLoS One 12(8):e0181346. https://doi.org/10.1371/journal.pone.0181346
Tapia-Rojas C, Burgos PV, Inestrosa NC (2016) Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid-beta (Abeta)42 peptides. J Neurochem 139(6):1175–1191. https://doi.org/10.1111/jnc.13873
Elliott C, Rojo AI, Ribe E, Broadstock M, Xia W, Morin P et al (2018) A role for APP in Wnt signalling links synapse loss with beta-amyloid production. Transl Psychiatry 8(1):179. https://doi.org/10.1038/s41398-018-0231-6
Bayod S, Mennella I, Sanchez-Roige S, Lalanza JF, Escorihuela RM, Camins A et al (2014) Wnt pathway regulation by long-term moderate exercise in rat hippocampus. Brain Res 1543:38–48. https://doi.org/10.1016/j.brainres.2013.10.048
Chen D, Zhang Y, Zhang M, Chang J, Zeng Z, Kou X et al (2020) Exercise attenuates brain aging by rescuing down-regulated Wnt/beta-catenin signaling in aged rats. Front Aging Neurosci 12:105. https://doi.org/10.3389/fnagi.2020.00105
Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L et al (2020) The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study. Alzheim Res Ther 12(1):1–11
Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer’s disease: targeting the cholinergic system. Curr Neuropharmacol 14(1):101–15
Schmitz TW, Nathan SR (2016) Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology. Nat Commun 7(1):1–13
Conner JM, Franks KM, Titterness AK, Russell K, Merrill DA, Christie BR et al (2009) NGF is essential for hippocampal plasticity and learning. J Neurosci 29(35):10883–10889
Pentz R, Iulita MF, Ducatenzeiler A, Bennett DA, Cuello AC (2021) The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Mol Psychiatry 26(10):6023–6037
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P et al (2016) Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheim Res Ther 8(1):1–11
Zilony-Hanin N, Rosenberg M, Richman M, Yehuda R, Schori H, Motiei M et al (2019) Neuroprotective effect of nerve growth factor loaded in porous silicon nanostructures in an Alzheimer’s Disease model and potential delivery to the brain. Small 15(45):1904203
Mitra S, Gera R, Linderoth B, Lind G, Wahlberg L, Almqvist P, Behbahani H, Eriksdotter M (2021) A review of techniques for biodelivery of nerve growth factor (NGF) to the brain in relation to Alzheimer’s disease. Adv Exp Med Biol 1331:167–191
Mitra S, Behbahani H, Eriksdotter M (2019) Innovative therapy for Alzheimer’s disease-with focus on biodelivery of NGF. Front Neurosci 13:38
Birch AM, McGarry NB, Kelly AM (2013) Short-term environmental enrichment, in the absence of exercise, improves memory, and increases NGF concentration, early neuronal survival, and synaptogenesis in the dentate gyrus in a time-dependent manner. Hippocampus 23(6):437–450
Pham TM, Söderström S, Winblad B, Mohammed AH (1999) Effects of environmental enrichment on cognitive function and hippocampal NGF in the non-handled rats. Behav Brain Res 103(1):63–70
Ickes BR, Pham TM, Sanders LA, Albeck DS, Mohammed AH, Granholm A-C (2000) Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp Neurol 164(1):45–52
Santoso D, Yolanda S, Redjeki S, Andraini T, Ivanali K (2020) Continuous environmental enrichment and aerobic exercise improves spatial memory: focus on rat hippocampal BDNF and NGF. Comparative Exercise Physiology 16(2):121–128
Fahnestock M, Michalski B, Xu B, Coughlin MD (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer’s disease. Mol Cell Neurosci 18(2):210–220
Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Rev Neurother 8(11):1703–1718
Ioannou MS, Fahnestock M (2017) ProNGF, but not NGF, switches from neurotrophic to apoptotic activity in response to reductions in TrkA receptor levels. Int J Mol Sci 18(3):599
Cuello AC, Bruno MA (2007) The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer’s disease. Neurochem Res 32(6):1041–1045
Allard S, Leon WC, Pakavathkumar P, Bruno MA, Ribeiro-da-Silva A, Cuello AC (2012) Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J Neurosci 32(6):2002–2012
Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ (2004) Reduction of cortical TrkA but not p75NTR protein in early-stage Alzheimer’s disease. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 56(4):520–531
Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ (2006) Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer’s disease. J Neurochem 97(2):475–487
Sclip A, Tozzi A, Abaza A, Cardinetti D, Colombo I, Calabresi P et al (2014) c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death Dis 5(1):e1019-e
Ploia C, Antoniou X, Sclip A, Grande V, Cardinetti D, Colombo A et al (2011) JNK plays a key role in tau hyperphosphorylation in Alzheimer’s disease models. J Alzheimers Dis 26(2):315–329
Savage MJ, Lin Y-G, Ciallella JR, Flood DG, Scott RW (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer’s disease model is associated with amyloid deposition. J Neurosci 22(9):3376–3385
Gourmaud S, Paquet C, Dumurgier J, Pace C, Bouras C, Gray F et al (2015) Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline. J Psychiatry Neurosci 40(3):151–161
Li G, Cong D, Sun P, Meng X (2018) Abeta1-42 regulates astrocytes through JNK/AP-1 pathway. Eur Rev Med Pharmacol Sci 22(7):2015–2021
Wei W, Norton DD, Wang X, Kusiak JW (2002) Aβ 17–42 in Alzheimer’s disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain 125(9):2036–2043
Patnaik A, Zagrebelsky M, Korte M, Holz A (2020) Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology. Sci Rep 10(1):1–14
Nakano R, Nakayama T, Sugiya H (2020) Biological properties of JNK3 and its function in neurons, astrocytes, pancreatic β-cells and cardiovascular cells. Cells 9(8):1802
Vogel J, Anand V, Ludwig B, Nawoschik S, Dunlop J, Braithwaite S (2009) The JNK pathway amplifies and drives subcellular changes in tau phosphorylation. Neuropharmacology 57(5–6):539–550
Colombo A, Bastone A, Ploia C, Sclip A, Salmona M, Forloni G et al (2009) JNK regulates APP cleavage and degradation in a model of Alzheimer’s disease. Neurobiol Dis 33(3):518–525
Marani M, Tenev T, Hancock D, Downward J, Lemoine NR (2002) Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 22(11):3577–3589
Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2(3):183–192
Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE et al (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315(5813):856–859
Yarza R, Vela S, Solas M, Ramirez MJ (2016) c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease. Front Pharmacol 6:321
Wisdom R, Johnson RS, Moore C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18(1):188–197
Bossy-Wetzel E, Bakiri L, Yaniv M (1997) Induction of apoptosis by the transcription factor c-Jun. EMBO J 16(7):1695–1709
Zhou Q, Wang M, Du Y, Zhang W, Bai M, Zhang Z et al (2015) Inhibition of c-J un N-terminal kinase activation reverses A lzheimer disease phenotypes in APP swe/PS 1dE 9 mice. Ann Neurol 77(4):637–654
Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ et al (2012) JNK3 perpetuates metabolic stress induced by Aβ peptides. Neuron 75(5):824–837
Yamamoto S, Kayama T, Noguchi-Shinohara M, Hamaguchi T, Yamada M, Abe K et al (2021) Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway. NPJ Sci Food 5(1):1–11
Hepp Rehfeldt SC, Majolo F, Goettert MI, Laufer S (2020) c-Jun N-terminal kinase inhibitors as potential leads for new therapeutics for Alzheimer’s diseases. Int J Mol Sci 21(24):9677
Cho H, Kang K (2020) Effects of environmental enrichment on neurotrophins in an mptp-induced Parkinson’s disease animal model: a randomized trial. Biol Res Nurs 22(4):506–513
Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M et al (2020) FGF/FGFR signaling in health and disease. Signal Transduct Target Ther 5(1):1–38
Abubakar M, Sanusi K, Ugusman A, Mohamed W, Kamal H, Ibrahim N, Khoo C, Kumar J (2022) Alzheimer’s disease: an update and insights into pathophysiology. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2022.742408
Alam R, Mrad Y, Hammoud H, Saker Z, Fares Y, Estephan E, Bahmad H, Harati H, Nabha S (2021) New insights into the role of fibroblast growth factors in Alzheimer’s disease. Mol Biol Rep 49:1413–1427
Chen X, Li Z, Cheng Y, Kardami E, Loh YP (2020) Low and high molecular weight FGF-2 have differential effects on astrocyte proliferation, but are both protective against Aβ-induced cytotoxicity. Front Mol Neurosci 12:328
Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T (2011) FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer’s disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci 108(49):E1339–E1348
Katsouri L, Ashraf A, Birch AM, Lee KK, Mirzaei N, Sastre M (2015) Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice. Neurobiol Aging 36(2):821–831
Seo JH, Yu JH, Suh H, Kim M-S, Cho S-R (2013) Fibroblast growth factor-2 induced by enriched environment enhances angiogenesis and motor function in chronic hypoxic-ischemic brain injury. PLoS One 8(9):e74405
Gómez-Pinilla F, So V, Kesslak JP (1998) Spatial learning and physical activity contribute to the induction of fibroblast growth factor: neural substrates for increased cognition associated with exercise. Neuroscience 85(1):53–61
Wang X, Meng ZX, Chen YZ, Li YP, Zhou HY, Yang M et al (2020) Enriched environment enhances histone acetylation of NMDA receptor in the hippocampus and improves cognitive dysfunction in aged mice. Neural Regen Res 15(12):2327–2334. https://doi.org/10.4103/1673-5374.285005
Cortese GP, Olin A, O’Riordan K, Hullinger R, Burger C (2018) Environmental enrichment improves hippocampal function in aged rats by enhancing learning and memory, LTP, and mGluR5-Homer1c activity. Neurobiol Aging 63:1–11. https://doi.org/10.1016/j.neurobiolaging.2017.11.004
Garcia EJ, Cain ME (2020) Environmental enrichment and a selective metabotropic glutamate receptor2/3 (mGluR2/3) agonist suppress amphetamine self-administration: Characterizing baseline differences. Pharmacol Biochem Behav 192:172907. https://doi.org/10.1016/j.pbb.2020.172907
Li XL, Hu N, Tan MS, Yu JT, Tan L (2014) Behavioral and psychological symptoms in Alzheimer’s disease. Biomed Res Int 2014:927804. https://doi.org/10.1155/2014/927804
Roberts R, Kaplan G, Shema S, Strawbridge W (1997) Does growing old increase the risk for depression? Am J Psychiatry 154:1384–1390
Burke AD, Goldfarb D, Bollam P, Khokher S (2019) Diagnosing and treating depression in patients with Alzheimer’s disease. Neurol Ther 8(2):325–350. https://doi.org/10.1007/s40120-019-00148-5
Huang H, Wang Q, Guan X, Zhang X, Zhang Y, Cao J, Li X (2021) Effects of enriched environment on depression and anxiety-like behavior induced by early life stress: a comparison between different periods. Behav Brain Res 411:113389
Brenes JC, Fornaguera J, Sequeira-Cordero A (2020) Environmental enrichment and physical exercise attenuate the depressive-like effects induced by social isolation stress in rats. Front Pharmacol 11:804. https://doi.org/10.3389/fphar.2020.00804
Cordner ZA, Marshall-Thomas I, Boersma GJ, Lee RS, Potash JB, Tamashiro KL (2021) Fluoxetine and environmental enrichment similarly reverse chronic social stress-related depression-and anxiety-like behavior, but have differential effects on amygdala gene expression. Neurobiol Stress 15:100392
Hendershott TR, Cronin ME, Langella S, McGuinness PS, Basu AC (2016) Effects of environmental enrichment on anxiety-like behavior, sociability, sensory gating, and spatial learning in male and female C57BL/6J mice. Behav Brain Res 314:215–225. https://doi.org/10.1016/j.bbr.2016.08.004
Pietropaolo S, Feldon J, Yee BK (2014) Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer’s disease. Cogn Affect Behav Neurosci 14(3):996–1008. https://doi.org/10.3758/s13415-014-0253-3
Hill AS, Sahay A, Hen R (2015) Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors. Neuropsychopharmacology 40(10):2368–2378
Shilpa BM, Bhagya V, Harish G, Srinivas Bharath MM, Shankaranarayana Rao BS (2017) Environmental enrichment ameliorates chronic immobilisation stress-induced spatial learning deficits and restores the expression of BDNF, VEGF, GFAP and glucocorticoid receptors. Prog Neuropsychopharmacol Biol Psychiatry 76:88–100. https://doi.org/10.1016/j.pnpbp.2017.02.025
Sztainberg Y, Kuperman Y, Tsoory M, Lebow M, Chen A (2010) The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1. Mol Psychiatry 15(9):905–917
Lopes DA, Souza TM, de Andrade JS, Silva MF, Antunes HK, Maluf LLS et al (2019) Anxiolytic and panicolytic-like effects of environmental enrichment seem to be modulated by serotonin neurons located in the dorsal subnucleus of the dorsal raphe. Brain Res Bull 150:272–280
Pereira PDC, Henrique EP, Porfirio DM, Crispim CCS, Campos MTB, de Oliveira RM et al (2020) Environmental enrichment improved learning and memory, increased telencephalic cell proliferation, and induced differential gene expression in Colossoma macropomum. Front Pharmacol 11:840. https://doi.org/10.3389/fphar.2020.00840
Hullinger R, O’Riordan K, Burger C (2015) Environmental enrichment improves learning and memory and long-term potentiation in young adult rats through a mechanism requiring mGluR5 signaling and sustained activation of p70s6k. Neurobiol Learn Mem 125:126–134
Lima MGP, Schimidt HL, Garcia A, Daré LR, Carpes FP, Izquierdo I et al (2018) Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity. Proc Natl Acad Sci 115(10):E2403–E2409
Grinan-Ferre C, Izquierdo V, Otero E, Puigoriol-Illamola D, Corpas R, Sanfeliu C et al (2018) Environmental enrichment improves cognitive deficits, AD hallmarks and epigenetic alterations presented in 5xFAD mouse model. Front Cell Neurosci 12:224. https://doi.org/10.3389/fncel.2018.00224
Li J-Z, Hao X-H, Wu H-P, Li M, Liu X-M, Wu Z-B (2021) An enriched environment delays the progression from mild cognitive impairment to Alzheimer’s disease in senescence-accelerated mouse prone 8 mice. Exp Ther Med 22(5):1–12
Stuart KE, King AE, King NE, Collins JM, Vickers JC, Ziebell JM (2019) Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice. Neuroscience 408:282–292
Zocher S, Overall RW, Lesche M, Dahl A, Kempermann G (2021) Environmental enrichment preserves a young DNA methylation landscape in the aged mouse hippocampus. Nat Commun 12(1):3892. https://doi.org/10.1038/s41467-021-23993-1
McDonald MW, Hayward KS, Rosbergen I, Jeffers MS, Corbett D (2018) Is environmental enrichment ready for clinical application in human post-stroke rehabilitation? Front Behav Neurosci 12:135
Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B (2016) Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res 77:42–51
Kvam S, Kleppe CL, Nordhus IH, Hovland A (2016) Exercise as a treatment for depression: a meta-analysis. J Affect Disord 202:67–86
Bridle C, Spanjers K, Patel S, Atherton NM, Lamb SE (2012) Effect of exercise on depression severity in older people: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 201(3):180–185. https://doi.org/10.1192/bjp.bp.111.095174
Catalan-Matamoros D, Gomez-Conesa A, Stubbs B, Vancampfort D (2016) Exercise improves depressive symptoms in older adults: an umbrella review of systematic reviews and meta-analyses. Psychiatry Res 244:202–209. https://doi.org/10.1016/j.psychres.2016.07.028
Meng Q, Lin M-S, Tzeng I (2020) Relationship between exercise and Alzheimer’s disease: a narrative literature review. Front Neurosci 14:131
Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L et al (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 108(7):3017–3022. https://doi.org/10.1073/pnas.1015950108
Kaufman CS, Honea RA, Pleen J, Lepping RJ, Watts A, Morris JK et al (2021) Aerobic exercise improves hippocampal blood flow for hypertensive apolipoprotein E4 carriers. J Cereb Blood Flow Metab 41(8):2026–2037. https://doi.org/10.1177/0271678X21990342
Zhidong C, Wang X, Yin J, Song D, Chen Z (2021) Effects of physical exercise on working memory in older adults: a systematic and meta-analytic review. Eur Rev Aging Phys Act 18(1):18. https://doi.org/10.1186/s11556-021-00272-y
Aghjayan SL, Bournias T, Kang C, Zhou X, Stillman CM, Donofry SD et al (2022) Aerobic exercise improves episodic memory in late adulthood: a systematic review and meta-analysis. Communications Medicine 2(1):1–11
Jia RX, Liang JH, Xu Y, Wang YQ (2019) Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis. BMC Geriatr 19(1):181. https://doi.org/10.1186/s12877-019-1175-2
Zhou Z, Wang P, Fang Y (2018) Social engagement and its change are associated with dementia risk among Chinese older adults: a longitudinal study. Sci Rep 8(1):1–7
Sommerlad A, Sabia S, Singh-Manoux A, Lewis G, Livingston G (2019) Association of social contact with dementia and cognition: 28-year follow-up of the Whitehall II cohort study. PLoS Med 16(8):e1002862. https://doi.org/10.1371/journal.pmed.1002862
Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL et al (2007) Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry 64(2):234–240. https://doi.org/10.1001/archpsyc.64.2.234
Hackett RA, Steptoe A, Cadar D, Fancourt D (2019) Social engagement before and after dementia diagnosis in the English longitudinal study of ageing. PLoS One 14(8):e0220195
James BD, Wilson RS, Barnes LL, Bennett DA (2011) Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc 17(6):998–1005. https://doi.org/10.1017/S1355617711000531
Kelly ME, Duff H, Kelly S, McHugh Power JE, Brennan S, Lawlor BA et al (2017) The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. Syst Rev 6(1):259. https://doi.org/10.1186/s13643-017-0632-2
Nie Y, Richards M, Kubinova R, Titarenko A, Malyutina S, Kozela M et al (2021) Social networks and cognitive function in older adults: findings from the HAPIEE study. BMC Geriatr 21(1):570. https://doi.org/10.1186/s12877-021-02531-0
Zhaoyang R, Scott SB, Martire LM, Sliwinski MJ (2021) Daily social interactions related to daily performance on mobile cognitive tests among older adults. PLoS One 16(8):e0256583
Teo AR, Choi H, Valenstein M (2013) Social relationships and depression: ten-year follow-up from a nationally representative study. PLoS One 8(4):e62396. https://doi.org/10.1371/journal.pone.0062396
Barger SD, Messerli-Burgy N, Barth J (2014) Social relationship correlates of major depressive disorder and depressive symptoms in Switzerland: nationally representative cross sectional study. BMC Public Health 14(1):273. https://doi.org/10.1186/1471-2458-14-273
Woods B, Aguirre E, Spector A, Orrell M (2012) Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd005562.pub2
Fukushima RLM, do Carmo EG, Pedroso RDV, Micali PN, Donadelli PS, Fuzaro GJ et al (2016) Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer’s disease: A systematic review. Dement Neuropsychol 10(3):178–84. https://doi.org/10.1590/S1980-5764-2016DN1003003
Carbone E, Gardini S, Pastore M, Piras F, Vincenzi M, Borella E (2021) Cognitive stimulation therapy for older adults with mild-to-moderate dementia in Italy: effects on cognitive functioning, and on emotional and neuropsychiatric symptoms. J Gerontol B Psychol Sci Soc Sci 76(9):1700–1710. https://doi.org/10.1093/geronb/gbab007
Aguirre E, Woods RT, Spector A, Orrell M (2013) Cognitive stimulation for dementia: a systematic review of the evidence of effectiveness from randomised controlled trials. Ageing Res Rev 12(1):253–262. https://doi.org/10.1016/j.arr.2012.07.001
Kim K, Han JW, So Y, Seo J, Kim YJ, Park JH et al (2017) Cognitive stimulation as a therapeutic modality for dementia: a meta-analysis. Psychiatry Investig 14(5):626–639. https://doi.org/10.4306/pi.2017.14.5.626
Orrell M, Yates L, Leung P, Kang S, Hoare Z, Whitaker C et al (2017) The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: a randomised controlled trial. PLoS Med 14(3):e1002269. https://doi.org/10.1371/journal.pmed.1002269
Maci T, Pira FL, Quattrocchi G, Nuovo SD, Perciavalle V, Zappia M (2012) Physical and cognitive stimulation in Alzheimer Disease. the GAIA Project: a pilot study. Am J Alzheimers Dis Other Demen 27(2):107–13. https://doi.org/10.1177/1533317512440493
Peña Y, Prunell M, Dimitsantos V, Nadal R, Escorihuela RM (2006) Environmental enrichment effects in social investigation in rats are gender dependent. Behav Brain Res 174(1):181–187
Lin EJ, Choi E, Liu X, Martin A, During MJ (2011) Environmental enrichment exerts sex-specific effects on emotionality in C57BL/6J mice. Behav Brain Res 216(1):349–357. https://doi.org/10.1016/j.bbr.2010.08.019
Cabrera-Muñoz EA, Olvera-Hernández S, Vega-Rivera NM, Juan M-S, Reyes-Haro D, Ortiz-López L et al (2022) Environmental enrichment differentially activates neural circuits in FVB/N mice, inducing social interaction in females but agonistic behavior in males. Neurochem Res 47(3):781–794
Grech AM, Ratnayake U, Hannan AJ, van den Buuse M, Hill RA (2018) Sex-dependent effects of environmental enrichment on spatial memory and brain-derived neurotrophic factor (BDNF) Signaling in a developmental “two-hit” mouse model combining BDNF haploinsufficiency and chronic glucocorticoid stimulation. Front Behav Neurosci 12:227. https://doi.org/10.3389/fnbeh.2018.00227
Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL et al (2010) Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington’s disease. PLoS One 5(2):e9077. https://doi.org/10.1371/journal.pone.0009077
Ohline SM, Abraham WC (2019) Environmental enrichment effects on synaptic and cellular physiology of hippocampal neurons. Neuropharmacology 145(Pt A):3–12. https://doi.org/10.1016/j.neuropharm.2018.04.007
Nguemeni C, McDonald MW, Jeffers MS, Livingston-Thomas J, Lagace D, Corbett D (2018) Short- and long-term exposure to low and high dose running produce differential effects on hippocampal neurogenesis. Neuroscience 369:202–211. https://doi.org/10.1016/j.neuroscience.2017.11.026
Singhal G, Morgan J, Jawahar MC, Corrigan F, Jaehne EJ, Toben C et al (2019) The effects of short-term and long-term environmental enrichment on locomotion, mood-like behavior, cognition and hippocampal gene expression. Behav Brain Res 368:111917. https://doi.org/10.1016/j.bbr.2019.111917
Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH et al (2002) The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci 22(5):1858–1867
Elder GA, Gama Sosa MA, De Gasperi R (2010) Transgenic mouse models of Alzheimer’s disease. Mt Sinai J Med 77(1):69–81. https://doi.org/10.1002/msj.20159
Levi O, Michaelson DM (2007) Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J Neurochem 100(1):202–210
Harburger LL, Lambert TJ, Frick KM (2007) Age-dependent effects of environmental enrichment on spatial reference memory in male mice. Behav Brain Res 185(1):43–48
Mora-Gallegos A, Rojas-Carvajal M, Salas S, Saborío-Arce A, Fornaguera-Trías J, Brenes JC (2015) Age-dependent effects of environmental enrichment on spatial memory and neurochemistry. Neurobiol Learn Mem 118:96–104
Trinchero MF, Herrero M, Monzon-Salinas MC, Schinder AF (2019) Experience-dependent structural plasticity of adult-born neurons in the aging hippocampus. Front Neurosci 13:739. https://doi.org/10.3389/fnins.2019.00739
Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC et al (2018) Data-driven models of dominantly-inherited Alzheimer’s disease progression. Brain 141(5):1529–1544. https://doi.org/10.1093/brain/awy050
Degroot A, Wolff MC, Nomikos GG (2005) Acute exposure to a novel object during consolidation enhances cognition. NeuroReport 16(1):63–67
Mustroph ML, Chen S, Desai SC, Cay EB, DeYoung EK, Rhodes JS (2012) Aerobic exercise is the critical variable in an enriched environment that increases hippocampal neurogenesis and water maze learning in male C57BL/6J mice. Neuroscience 219:62–71
Lambert TJ, Fernandez SM, Frick KM (2005) Different types of environmental enrichment have discrepant effects on spatial memory and synaptophysin levels in female mice. Neurobiol Learn Mem 83(3):206–216
Tarsa L, Goda Y (2002) Synaptophysin regulates activity-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci 99(2):1012–1016
Fletcher TL, Cameron P, De Camilli P, Banker G (1991) The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture. J Neurosci 11(6):1617–1626
Ekstrand J, Hellsten J, Tingström A (2008) Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex. Neurosci Lett 442(3):203–207
Bailoo JD, Murphy E, Boada-Sana M, Varholick JA, Hintze S, Baussiere C et al (2018) Effects of cage enrichment on behavior, welfare and outcome variability in female mice. Front Behav Neurosci 12:232. https://doi.org/10.3389/fnbeh.2018.00232
Liu PZ, Nusslock R (2018) Exercise-mediated neurogenesis in the hippocampus via BDNF. Front Neurosci 12:52
Sleiman SF, Henry J, Al-Haddad R, El Hayek L, AbouHaidar E, Stringer T et al (2016) Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. Elife 5:e15092
Hall JM, Gomez-Pinilla F, Savage LM (2018) Nerve growth factor is responsible for exercise-induced recovery of septohippocampal cholinergic structure and function. Front Neurosci 12:773
Kobilo T, Liu Q-R, Gandhi K, Mughal M, Shaham Y, van Praag H (2011) Running is the neurogenic and neurotrophic stimulus in environmental enrichment. Learn Mem 18(9):605–609
Fabel K, Wolf S, Ehninger D, Babu H, Leal-Galicia P, Kempermann G (2009) Additive effects of physical exercise and environmental enrichment on adult hippocampal neurogenesis in mice. Front Neurosci. https://doi.org/10.3389/neuro.22.002.2009
Lu L, Bao G, Chen H, Xia P, Fan X, Zhang J et al (2003) Modification of hippocampal neurogenesis and neuroplasticity by social environments. Exp Neurol 183(2):600–609
Madronal N, Lopez-Aracil C, Rangel A, Del Río JA, Delgado-Garcia JM, Gruart A (2010) Effects of enriched physical and social environments on motor performance, associative learning, and hippocampal neurogenesis in mice. PLoS One 5(6):e11130
Buschler A, Manahan-Vaughan D (2012) Brief environmental enrichment elicits metaplasticity of hippocampal synaptic potentiation in vivo. Front Behav Neurosci 6:85
Fares RP, Belmeguenai A, Sanchez PE, Kouchi HY, Bodennec J, Morales A et al (2013) Standardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats. PLoS One 8(1):e53888
Moreno-Jiménez EP, Jurado-Arjona J, Ávila J, Llorens-Martín M (2019) The social component of environmental enrichment is a pro-neurogenic stimulus in adult c57BL6 female mice. Front Cell Dev Biol 7:62
Eckert MJ, Bilkey DK, Abraham WC (2010) Altered plasticity in hippocampal CA1, but not dentate gyrus, following long-term environmental enrichment. J Neurophysiol 103(6):3320–3329
Zocher S, Schilling S, Grzyb AN, Adusumilli VS, Bogado Lopes J, Günther S et al (2020) Early-life environmental enrichment generates persistent individualized behavior in mice. Sci Adv 6(35):eabb1478
Lin E-JD, Sun M, Choi EY, Magee D, Stets CW, During MJ (2015) Social overcrowding as a chronic stress model that increases adiposity in mice. Psychoneuroendocrinol 51:318–30
Lee Y-A, Obora T, Bondonny L, Toniolo A, Mivielle J, Yamaguchi Y et al (2018) The effects of housing density on social interactions and their correlations with serotonin in rodents and primates. Sci Rep 8(1):1–13
Gonzalez-Pardo H, Arias JL, Vallejo G, Conejo NM (2019) Influence of environmental enrichment on the volume of brain regions sensitive to early life stress by maternal separation in rats. Psicothema 31(1):46–52. https://doi.org/10.7334/psicothema2018.290
Bhagya VR, Srikumar BN, Veena J, Shankaranarayana Rao BS (2017) Short-term exposure to enriched environment rescues chronic stress-induced impaired hippocampal synaptic plasticity, anxiety, and memory deficits. J Neurosci Res 95(8):1602–1610
Herring A, Ambrée O, Tomm M, Habermann H, Sachser N, Paulus W et al (2009) Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol 216(1):184–192
Beauquis J, Pavía P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V et al (2013) Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer’s disease. Exp Neurol 239:28–37
Acknowledgements
The authors would like to thank Jeffery Cheah School of Medicine and Health Science for their constant support. A.L.K.Y. is a recipient of Monash University Malaysia graduate research tuition fee waiver.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions
Author information
Authors and Affiliations
Contributions
A.L.K.Y. wrote the manuscript. T.C.H and T.S. supervised, reviewed, edited, and finalized the paper. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liew, A.K.Y., Teo, C.H. & Soga, T. The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease. Mol Neurobiol 59, 7095–7118 (2022). https://doi.org/10.1007/s12035-022-03016-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-022-03016-w